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CHAPTER 1. INTRODUCTION 
1    Introduction 
Lysosomes, the acidic subcellular compartments serve as one of the major sites for 
intracellular degradation. This function is attributed to a broad variety of hydrolytic enzymes 
and transport proteins that function in tandem. The substrates for degradation are targeted to 
the lysosomes mainly by vesicular transport such as endocytosis and autophagocytosis. Most 
of the lysosomal matrix proteins are soluble hydrolases whereas the transmembrane proteins 
are responsible for transport processes across the membranes. They are also involved in 
communication with the surrounding cytosol and other organelles like late endosomes. These 
proteins bear one or more membrane spanning segments with their luminal protrusions and 
loops usually glycosylated as a means of protection against lysosomal self-digestion (Peters 
and von Figura, 1994).  
 
One of the transport proteins, the vacuolar ATPase (V-ATPase) is in charge of 
acidification of the lysosomes and the others are concerned with disposal of degradation 
products. The turn-over of cellular proteins, down-regulation of surface receptors, release of 
endocytosed nutrients, inactivation of pathogenic organisms, repair of plasma membrane, and 
processing of antigens to be loaded for antigen presentation are the other functions, these 
proteins are involved in (Eskelinen et al., 2003). 
 
There exist at least 40 distinct inherited disorders sharing the common name 
lysosomal storage disorders, caused by a deficiency in a single lysosomal enzyme or a 
cofactor leading to the accumulation of one or several natural compounds in the lumen of the 
lysosomes (Winchester et al., 2000). In diseases like Hermansky-Pudlak syndrome (White, 
1982), the membrane and morphology of the lysosomes are affected that alter immunological 
as well as pigmentation functions. The functions of several lysosomal membrane proteins are 
known as exemplified by the corresponding genetic diseases, those of LAMP II in Danon 
disease (Nishino et al., 2000), Sialic acid transporter in Salla disease (Verheijen et al., 1999) 
and Cystine transporter in Cystinosis (Town et al., 1998). If the vacuolar type ATPase on the 
lysosomal membrane functioning as the proton pump to maintain the acidic environment of 
the lysosomal lumen is inefficient in either cleaving the ATP or transporting protons, 
accumulation of lipofuscin derivatives in the retinal pigment epithelial cells results. 
Accumulation of lipofuscin derivatives is one factor behind the pathology of age-related 
macular degeneration (Bergmann et al., 2004) that results in a loss of vision. 
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The lysosomal hydrolases, especially several cysteine proteases which are known to 
be part of the degradation machinery, are involved in specialised functions within the cells, as 
suggested by their roles in matrix remodeling, regulating the immune responses, and 
involvement in certain lung diseases (Wolters and Chapman, 2000). From this perspective, a 
proteomic investigation of the lysosomal protein complexes, mainly those are associated with 
the membrane not only provides an overall view of the number and variety of proteins that are 
part of the organelle, but also of the special interactions among these proteins and with the 
membrane lipids. 
 
1.1  Lysosome-the organelle 
Christian R. de Duve, a Belgian scientist was the first to identify the degradative bags within 
the cells in 1949, which were later termed lysosomes (de Duve, 2005). He was investigating 
hepatic enzymes that are involved in diabetes. The experiments for separating the components 
of cells by centrifugation resulted in the release of acid phosphatase proportionately to the 
damage of cell compartments during the homogenisation and subfractionation procedures 
(de Duve et al., 1955). De Duve proposed that the cells contain membranous sacs enclosing 
acid phosphatase and functioning as `digestive bodies`. In 1974, he was rewarded for this 
discovery with the Nobel Prize in medicine that he shared with Albert Claude and George 
Palade. 
 
The polymorphisms among the lysosomal populations have been well studied (Rome 
et al., 1979, Kelly et al., 1989) where the sub populations differ in their density as well as 
morphology. The denser lysosomes are rather spherical small bodies while the more buoyant 
ones are bigger multi-vesciculated structures. Both these populations contain the markers for 
lysosomes in similar proportions, such as the acid phosphatase. It has also been reported that 
oxidative stress results in variability among the lysosomal populations not only among 
different cell types, but also among the cells of the same type (Nilsson et al., 1997). 
 
The lysosomal membrane, a dynamic platform of 7-10 nm thickness (Winchester et 
al., 2000) with a low electron density on the luminal face. It is composed mainly of 
phospholipids, cholesterol, and the resident membrane proteins. From the rat liver lysosomes, 
the phospholipid composition of the membrane has been evaluated. The results show high 
proportions of phosphatidyl choline (41.6%), phosphatidyl ethanolamine (27.3%), 
phosphatidyl inositol (9.4%) and sphingomyelin (9.1%) (Bleistein et al., 1980). Among the 
fatty acids in the phospholipids, those with 16-20 carbon atoms were the most abundant 
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(Henning and Heidrich, 1974). These membranes are also enriched in cholesterol with 
cholesterol:phospholipid ratio of 0.4-0.5 (mol/mol) reported from tritosomes. They contained 
LDL-cholesterol, esterified cholesterol, and triglycerides (Johnson et al., 1997, Schoer et al., 
2000). Presence of detergent resistant microdomains on the lysosomal membranes prepared 
from human placenta has been reported (Taute et al., 2002), where special proteins are 
localised, but more information is yet to be obtained. 
 
1.2  Synthesis and trafficking of lysosomal proteins 
The lysosomal membrane proteins such as the acid phosphatase precursor may follow the 
constitutive secretory pathway via the cell surface and endocytosis (Hunziker and Geuze, 
1996). However, the delivery of most of these proteins appears to proceed through a direct 
pathway after exiting the trans-Golgi network in clathrin-coated vesicles and fusing with 
early and late endosomes (Rouille et al., 2000). The sorting process is highly dependent on 
specific signals encoded in the cytosolic domain of these proteins. The lysosomal targeting 
signals are either tyrosine-based or di-leucine- based.  These signals are necessary for the 
binding of clathrin adapter proteins (APs) either at the trans-Golgi network (AP-1) or at the 
plasma membrane (AP-2) (Honing et al., 1996). The third member of this family, AP-3 
operates through a distinct mechanism where it`s release from the membranes is regulated by 
a small GTP binding ADP-ribosylation factor, the Arf. The GTP hydrolysis by the Arf is the 
key step in detachment of AP-3 complex from the membranes (Simpson et al., 1997). The 
AP-4 is involved in protein sorting from TGN or endosomes to lysosomes (Dell`Angelica et 
al., 1999).  
 
  The GGAs (Golgi-localised γ-ear-containing, Arf binding proteins) are a group of 
recently identified (Hirst et al., 2000) highly conserved clathrin adaptor proteins facilitating 
cargo transport and vesicle formation at the TGN (Boman, 2001). Their involvement in the 
trafficking of cargo molecules such as mannose-6-phosphate receptors has been reported 
(Ghosh et al., 2003). 
                                                                                                     
Table. 1.1:  Endosomal/lysosomal sorting signals (Bonifacino and Traub, 2003) 
 
  Signal type           Recognition protein/domain           Function 
 
   NPXY              Clathrin terminal domain               Internalisation                                    
AP-2 µ2 subunit 
PTB domain of Dab-2 
YXX∅         µ subunit of AP complexes            Internalisation   
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                                                                                             Lysosomal targeting 
                                                                                             Basolateral targeting 
 
[DE] XXXL[LI]   µ and ß subunits of AP complexes    Internalisation   
                                                                                               Lysosomal targeting 
                                                                                               Basolateral targeting 
 
DXXLL                VHS domain of the GGAs               TGN to endosomes 
 
Acidic cluster        PACS-1                                        Endosomes to TGN 
 
FW-or P-rich       TIP47                                             Endosomes to TGN 
 
NPFX(1,2)D         SHD1 domain of S. cer S1a1P        Internalisation  
 
Ubiquitin             UBM, UBA and UBC domains       Internalisation 
                                                                                           Lysosomal/vacuolar targeting 
              
 
 Amino acids are designated based on single letter codes. X stands for any amino acid and 
∅ for amino acids with bulky hydrophobic chains. Abbreviations: PTB, phospho tyrosine 
binding; Dab2; disabled-2; AP, adapter protein; VHS; domain present in vps27p, hrs, stam; 
GGAs, Golgi-localized γ-ear-containing, Arf binding proteins; PACS-1, phosphofurin acidic 
cluster sorting protein 1; TIP47, tail interacting protein of 47 kDa; SHD1; sla 1p homology 
domain 1; UBA, ubiquitin associated; UBC, ubiquitin conjugating; UIM, ubiquitin interaction 
motif                                     
                                                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1.1: Sorting 
pathways for 
lysosomal membrane 
proteins (Bonifacino 
and Traub, 2003) 
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Though these systems for the trafficking of membrane proteins in to the lysosomal 
compartment are well studied, a possibility of alternate mechanisms operating for special 
proteins cannot be excluded.  
 
The lysosomal matrix proteins are synthesised in the rough endoplasmic reticulum 
(ER) with a signal peptide for their targeting to the ER lumen. Removal of this signal peptide 
is followed by N-glycosylation and the proteins are transferred to the cis-Golgi complex in 
transport vesicles. A phophotransferase within the Golgi recognises the proteins and modifies 
them with N-acetyl glucosaminyl phosphoryl residues (Yaghootfam et al., 2003). In trans-
Golgi, the diester residues are hydrolysed thus uncovering the terminal mannose-6-phosphate 
residues (Steet et al., 2005). These unmasked mannose-6-phosphate moieties are recognised 
by the mannose 6-phosphate receptors that bind and carry the proteins to early endosomes. 
From the late endosomes, the receptors are recycled to the trans-Golgi network. 
 
1.3  Lysosomal membrane proteins 
The lysosomal membrane contains a number of proteins with diverse functions. There are 
more than 20 transport proteins that are characterised functionally on the lysosomal 
membranes- like those involved in the transport of amino acids and peptides (Pisoni et al., 
1987, Zhou et al., 2000), carbohydrates (Mansini et al., 1990, Jonas and Jobe, 1990), vitamin 
B12 (Idriss and Jonas, 1991), phosphate (Pisoni 1991), sulphate (Jonas and Jobe, 1990) and 
nucleosides (Pisoni and Thoene, 1989). However, little information regarding these proteins is 
available to date. In relative abundance, about half of the total membrane proteins in 
lysosomes are lysosome associated membrane proteins (LAMPs) and lysosomal integrated 
membrane proteins (LIMPs), which differ in the number of transmembrane segments and 
glycosylation patterns.  
 
1.3.1  The LAMPs 
LAMPs are a group of type I membrane proteins with single membrane spanning segmant and 
a short cytosolic C-terminus of 10-20 residues (Wickner and Lodish, 1985) where the 
lysosomal targeting signal is situated. In humans there are 2 forms of LAMP denoted as 
LAMP-1 (90-120 kDa) and LAMP-2 (110-120 kDa). These proteins carry complex N-linked 
as well as O-linked oligosaccharides. Their expression in cancer cells are characterised by 
increased sialylation and ß1-6-linked branching within the complex-type asparagine  
(Asn)-linked oligosaccharides as compared to the normal cells (Furuta et al., 2001). The 
functions of LAMP proteins include autophagy (Majeski and Dice, 2004) and lysosomal 
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biogenesis (Eskelinen et al., 2003). LAMP-1 is considered to be house keeping protein that 
can be functionally substituted with LAMP-2, whereas a deficiency of LAMP-2 leads to 
Danon disease characterised by fatal cardiomyopathy and myopathy (Nishino et al., 2000, 
Saftig et al., 2001). Initially, this disease was biochemically characterised as a vacuolar 
glycogen storage disease (Uzuki et al., 1994) with normal acid glucosidase activity. Later, it 
was observed that in affected cells, autophagosomal sequestration is functioning, whereas the 
delivery of the lysosomal enzymes to autophagosomes is missing (Nishino, 2003).  
 
1.3.2  The LIMPs 
The LIMPs are type-III membrane proteins with both the N and C termini oriented towards 
the cytosolic side (Barriocanal et al., 1986). LIMP-1 also called LAMP-3 (identical to CD 63) 
is a membrane protein with four transmembrane segments while LIMP-2 or LGP 85 (Tabuchi 
et al., 1997) has two membrane spanning segments. LIMP-II is reported to have important 
functions in maintaining endosomal transport as well as a role in lysosomal biogenesis 
(Eskelinen et al., 2003). 
 
1.3.3  Lysosomal proton pump (vacuolar ATPase) 
The lysosomal membrane ATPase complex belongs to the family of vacuolar proton pumps 
(V-ATPase). It performs the acidification of intracellular compartments such as endosomes, 
lysosomes and secretory vesicles. For the first time it was purified to homogeneity from rat 
liver lysosomes (Arai and Shimaya, 1992). The acidification of these subcellular organelles 
by vacuolar ATPase (V-ATPase) is of high importance for many physiological functions 
including receptor mediated endocytosis, intracellular traffic, zymogen activation and 
degradation, homeostasis, neurotransmitter storage and release and entry of certain viruses 
and toxins from endocytic compartments into cytosol (Nelson, 1992, Nishi and Forgac, 2002). 
In specialised types of insect and vertebrate cells, V-ATPases are seen in high amounts in the 
plasma membrane where they pump protons from cytosol out of the cell (Gluck, 1992). 
 
Similar to the mitochondrial enzyme, the vacuolar ATPase consists of two domains 
(Nelson N, 1989). They are referred to as a water soluble V1, and a membrane bound V0 
domain. ATP hydrolysis taking place on the V1 is coupled to proton transport through V0. The 
V1 domain is comprised of 8 subunits with a total molecular weight of 600- 650 kDa and a 
subunit stoichiometry A3 B3 C1 D1 E1 F1 G2 H1-2. The membrane inserted V0 domain forms a 
complex of 250 kDa with a subunit structure, a1 d1 e(x) c4 c` c `` (Arai et al., 1988). Most of 
the subunits are conserved to a high extent in all eukaryotes. In addition to the above-
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mentioned subunits there are two accessory subunits mentioned as Ac45 (Supek et al, 1994) 
and M8-9 (Ludwig et al, 1998) are reported. The vacuolar ATPase subunits share sequence 
similarities with mitochondrial, chloroplast, and bacterial enzymes reflecting an evolutionary 
relationship (Kane, 1995). Depending on the tissue, several subunits are represented by 
alternative forms. 
 
The ATP driven proton transport depends on a functional and structural coupling of 
the two sectors. A reversible disassembly of the domains seems to be an important regulatory 
mechanism for silencing the ATPase activity and conserving the ATP (Merzendorfer et al., 
1997). It should be mentioned that in eubacteria and plants several subunits that are part of the 
catalytic domain could dissociate from the complex upon cold incubation rendering the 
enzyme biologically inactive (Moriyama and Nelson, 1989). 
 
 
 Fig. 1.2: Structure of yeast 
vacuolar ATPase (S. cerevisiae). 
 
(Wilkens et al., 2004) 
The catalytic V1 domain is coupled to
the membrane-inserted V0 domain,
responsible for proton translocation.
The catalytic sites (A3B3) are kept in
position by the stator subunits
(C,E,G,H and a). Upon ATP cleavage
the rotatory subunits (D and F)
effects a structural re-arrangement
and proton translocation is achieved
by a combined functioning of
a,c,c`and c`` thereby acidifying the
luminal compartments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Many of the vacuolar ATPase subunits are expressed as tissue-specific isoforms. A 
complete list of vacuolar ATPase subunits in humans and their isoforms is given below (Table. 
1.2). The nominal molecular weights and theoretical isoelectric points are calculated using the 
Expasy proteomics server (http://www.expasy.ch/). 
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    Table. 1.2: Human V-ATPase subunits and isoforms 
Domain 
 
Subunit 
 
MW 
(kDa) 
pI 
 
Gene code 
 
Function and location 
within the complex 
 
 
 
 
 
 
 
 
 
V1
 
A 
B1 
B2 
C1 
C2 
D 
E1 
E2 
F 
G1 
G2 
G3 
H 
70 
56 
58 
42 
42 
34 
31 
26 
14 
13 
13 
13 
50 
5.3 
5.52 
5.57 
7.02 
5.72 
9.36 
7.7 
8.79 
5.29 
8.93 
10.26 
9.16 
6.07 
ATP6V1A 
ATP6V1B1 
ATP6V1B2 
ATP6V1C1 
ATP6V1C2 
ATP6V1D 
ATP6V1E1 
ATP6V1E2 
ATP6V1F 
ATP6V1G1 
ATP6V1G2 
ATP6V1G3 
ATP6V1H 
catalytic ATP binding 
non catalytic ATP binding 
non catalytic ATP binding 
peripheral stator 
peripheral stator 
central rotor 
peripheral stator 
peripheral stator 
central rotor 
peripheral stator 
peripheral stator 
peripheral stator 
peripheral stator 
 
 
 
 
V0
 
a1 
a2 
a3 
a4 
d1 
d2 
c 
c` 
c`` 
100 
98 
93 
96 
40 
40 
16 
21 
9 
6.02 
6.18 
6.58 
5.75 
4.89 
5.18 
7.98 
7.61 
8.96 
ATP6V0A1 
ATP6V0A2 
ATP6V0A3 
ATP6V0A4 
ATP6V0D1 
ATP6V0D2 
ATP6V0C 
ATP6V0B 
ATP6V0E 
peripheral stator, H+ pump 
peripheral stator, H+ pump 
peripheral stator, H+ pump 
peripheral stator, H+ pump 
non integral component 
non integral component 
rotor, H+  translocation
rotor, H+ translocation 
rotor, H+  translocation 
 
There are reported impairment of biological activity of this protein complex in the 
retinal pigment epithelial cells due to accumulation of lipids and lipid peroxidation products 
(Kopitz et al., 2004). Such events alter the lysosomal pH and accumulation of auto-
fluorescent products occur leading to age-related macular degeneration (ARMD) and vision 
loss. It has been shown that a major lipofuscin derivative A2-E can inhibit the lysosomal 
proton pump on a dose-dependent manner (Bergmann et al., 2004) though there are several 
environmental as well as genetic factors mentioned playing a role in the pathogenesis of 
ARMD (Klein et al., 2004, Zurdel and Richard, 2002).  
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The pyridinium retinoid, A2-E is derived from two molecules of vitamin A, and one molecule 
of ethanolamine and thus acquired the name.  
 
 
 Fig. 1.3: The Structure of A2-E 
(Kopitz et al., 2004) 
 
 
 
 
 
 
1.3.4  Niemann-Pick C1 protein 
The Niemann-Pick C1 (NPC-1) protein involved in cholesterol trafficking is composed of 
1278 amino acids, bearing 13 potential transmembrane segments and 14 potential 
glycosylation sites. NPC-1 localises mostly to the endosomes (Ioannou, 2000). The di-leucine 
motif required for the lysosomal targeting is conserved in a short cytoplasmic tail region. 
There exist multiple signals for the proper targeting of this protein including the one located at 
the sterol-sensing domain of the protein (Scott and Ioannou, 2004). A defect in this protein 
leads to the pathological condition termed Niemann-Pick C disease, characterised by 
cholesterol accumulation in lysosomes and a severe progressive neurodegeneration (Maxfield 
and Tabas, 2005). A feedback regulation of cholesterol homeostasis within the cells (Davies 
et al., 2000) suggests its role in transporting LDL derived-cholesterol. The recent 
investigations showing an abundance of this protein in the axons of sympathetic neurons and 
recycling endosomes in the pre-synaptic nerve terminals suggests a relatively uncharacterised 
role of this protein in the pre-synaptic nerve terminal (Karten et al., 2005). 
 
1.3.5  Acetyl CoA: α-glucosaminide N-acetyl transferase 
Acetyl CoA: α glucosaminide N-acetyl transferase (EC 2.3.1.3) is involved in the degradation 
of heparan sulphate within the lysosomal compartment. It transfers acetyl groups to the 
terminal alpha glucosamine residues that become exposed during the step-wise degradation of 
heparan sulphate (Bame and Rome, 1986). The enzyme is shown to function in a two-step 
reaction comprising of (1) acetylation of the enzyme and then (2) transferring the acetyl group 
to glucosamine residue through a ping- pong mechanism. An irreversible and specific 
inhibition of the enzyme activity by N-bromosuccinimide indicates the presence of an active 
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site histidine residue. Association of this protein with detergent resistant microdomains within 
the lysosomal membrane has been recently reported by our group (Taute et al., 2002). 
 
A deficiency of this enzyme is the cause of the Sanfilippo- C disease also called 
mucopolysaccharidosis type IIIC. This disease is characterised by dysmorphic signs including 
coarse facies, hypertelorism, low-set ears, depressed nasal bridge and coarse hair in the early 
childhood (Sewell et al., 1988). 
 
At present, there is not much information available about either the structure of the 
protein or the gene that codes the enzyme. A genome wide scans on 44 MPS IIIC patients and 
their unaffected relatives from 31 families were carried out recently. Several of the families 
were consanguineous. An analysis of excess homozygosity in patients and identity in state of 
genotypes among affected relatives indicated the gene to be localised on chromosome 8. From 
a linkage analysis (Ausseil et al., 2004) it was suggested that an 8.3-cM interval in the 
pericentromeric region of chromosome 8 encodes this protein. 
 
Using biochemical techniques, an acetylated transmembrane protein from the 
placental lysosomal membranes was isolated, which was missing in the MPS type IIIC 
(Ausseil et al., 2006). The specific activity of this candidate protein of 240 kDa molecular 
weight was highly dependent on the concentration suggesting an oligomeric nature of the 
protein complex. 
 
1.3.6  The CLN proteins 
The neuronal ceroid lipofuscinoses are a group of recessively inherited storage disorders in 
which autofluorescent inclusions of  lipofuscin are observed in the lysosomes. The 8 different 
forms of this disease share similar clinical and pathological abnormalities. The main features 
of this disease are failure of psychomotor development, impaired vision, seizures, and 
premature death. The proteins deficient in this disorder are either transmembrane proteins 
(CLN3 and CLN8) or lysosomal hydrolases (CLN1, CLN2 and CLN5) (Mitchison and Mole, 
2001, Zhong et al., 2000).  
 
The CLN3 gene product is a 438 amino acid long peptide with 5 transmembrane 
segmants and a dileucine motif at the C terminal domain. This protein is defective in the 
juvenile form of ceroid lipofuscinosis (Boriack and Bennet, 2001). There are recent reports 
that both CLN6 (Mole et al., 2004) and CLN8 (Lonka et al., 2000) are resident ER membrane 
proteins.  
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The CLN1 protein is a palmitoyl protein thioesterase that is localised in the lysosomal matrix. 
The CLN2, a lysosomal matrix serine protease with a tripeptidyl peptidase-1 activity is 
defective in the late infantile neuronal ceroid lipofuscinosis. This is characterised by 
accumulation of the subunit c of ATP synthase within the lysosomes (Ezaki et al., 1999). It 
has been reported to possess interaction with the matrix protein CLN3 as well as the 
membrane protein CLN5 (Vesa et al., 2002). However the recent results suggest the CLN5 
protein of 60 kDa molecular weight to be a lysosomal matrix glycoprotein  (Isosomppi et al., 
2002). 
 
1.3.7   Other transport proteins in the lysosomal membrane 
In addition to the above-mentioned, there are a few relatively uncharacterised proteins located 
on the lysosomal membrane. Among them is an anion transporter, the mutation of which 
causes an autosomal recessive neurodegenerative disorder called sialic acid storage disease. 
The lysosomes are enlarged and abnormal amounts of sialic acid are excreted through urine in 
the affected individuals. The gene coding for the protein was designated SLC17A5 generating 
a polypeptide of 57 kDa (Verheijen et al., 1999). 
 
Cystinosis is another common lysosomal storage disorder caused by a defect in the 
transport of cystine out of the lysosomes (Town et al., 1998). The gene responsible for this 
defect, mentioned CTNS is mapped to chromosome 17p13 and codes a 367aminoacid long 
polypeptide that does not require ATP for transporting cystine (Gahl et al., 1993). The 
pathology is associated with less opacities and renal tubular dysfunction leading to a fatal 
electrolyte imbalance. 
 
The ATP-binding cassette transporters are involved in the energy-dependent transport 
of a variety of substrates across the organellar membranes. A few members of this category 
have been identified to be residing in the lysosomal membrane including ABCA2 (Zhou et 
al., 2000), which was cloned and characterised recently (Vulevic et al., 2001). Another 
transmembrane protein, designated ABCB9 with a lysosomal localisation was cloned (Zhang 
et al., 2000). This protein with an unknown function is phylogenetically connected to TAP1 
and TAP2 found in the endoplasmic reticulum. The new member of this group is ABCA5, a 
protein composed of 1642 amino acids. An experimentally created defect of this protein 
showed symptoms of several lysosomal diseases in mouse (Kubo et al., 2005), but the 
function is not yet known. 
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2  Aims and objectives  
The lysososomal membrane carries a number of highly hydrophobic proteins involved in the 
transport of nutrients and cleaning up of the degradation products. The transport processes 
these proteins are involved in are of high importance as a defective protein can lead to 
accumulation of bio-molecules within the lysosomes with lethal consequences. Though 
functionally characterised, there are several proteins that are not isolated or cloned. The main 
goal of this study is to purify the lysosomal membrane proteins from placental preparations 
and analyse the protein complexes associated with the compartment. 
 
            The lysosomal membrane provides a platform where interactions among proteins and 
in between proteins and lipids take place forming supra-molecular complexes. Presence of 
detergent resistant microdomains (DRM) on the lysosomal membranes have been published 
(Taute A et al., 2003), where special proteins are found to be enriched including the Acetyl-
CoA: α-glucosaminide N-acetyl transferase, a mutation of which causes Sanfilippo- C 
syndrome. Though the pathology is known, there is not much information currently available 
about neither the protein nor the gene involved. At this perspective, a proteomic analysis of 
the microdomains on the lysosomal membrane will provide a new insight into the number and 
variety of proteins associated with the DRMs, the kind of interactions the proteins possess 
with the lipids and a possibility to identify and characterise the Sanfilippo C protein.  
 
            The vacuolar ATPase required for the acidification of intra-cellular compartments 
have been mentioned to be DRM associated (Galli et al., 1996, Blonder et al., 2004, 
Yoshinaka et al., 2004), and characterisation of DRMs from the lysosomal membrane might 
improve the current information regarding this observation. Isolation of the V-ATPase 
complex can be helpful in understanding the role of special lipids on the biological activity by 
reconstitution experiments. These investigations can be of importance as the lipid and lipid 
peroxidation products are reported inhibitors of V-ATPase in vivo, resulting in pathological 
conditions such as age-related macular degeneration. Isolation and reconstitution of this 
protein complex can be thus useful as some in vitro activity studies can be performed in 
presence of synthetic compounds that are relevant to this disease. 
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3  Materials and methods 
     
     3.1   Materials   
 
3.1.1      Chemicals 
All chemicals were stored as per manufacturer's instructions. Doubly deionised water 
from a water purifying system (Milli Q UF from Millipore, Erkrath) was used for 
dissolving the chemicals in all experiments, unless otherwise specified. 
 
Acetic acid Merck   Darmstadt                                       
Acetyl coenzyme A Sigma   Mannheim 
Acetone Merck   Darmstadt 
Acetonitrile Merck   Darmstadt 
ß-N-Acetyl glucosaminidase Sigma   Taufkirchen 
Adenosine diphosphate Boehinger  Mannheim 
Adenosine triphosphate Roche  Baton Rouge,  
   USA 
Adenosine monophosphate Boehinger             Mannheim 
Ala-Ala-Phe-Ala-7-amido-4-methyl coumarine Sigma   Taufkirchen 
ATP-Binders resin™ Merck   Darmstadt  
Agarose Sea Plaque Biozyme  Heidelberg 
ß-Aminocaproic acid Riedel-de Haen Seelze 
Ampholytes (Servalyte 3-7, 4-7, 5-7, 7-9, 3-10) Serva   Heidelberg 
Ammonium molybdate Sigma                         Taufkirchen    
Ammonium peroxisulphate Bio-Rad  Munich 
Ascorbic acid Merck    Darmstadt      
ASB-14      Calbiochem  Bad Soden 
Bafilomycin-A1     LC laboratories MA, USA  
Boric acid      Merck   Darmstadt 
Cetyltrimethylammonium bromide (CETAB) Merck   Darmstadt 
3-[(3-Cholamidopropyl)-dimethylammonio]-   Calbiochem   Bad Soden 
propanesulfonate (CHAPS)      
Chloroform     Riedel-de Haen Seelze 
Cholesterol           Sigma    Taufkirschen 
Coomassie blue (Brilliant blue G 250)  Serva   Heidelberg 
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Diaminobenzidine Sigma   Taufkirschen 
Diethyl ether      Roth      Karlsruhe 
Diphenyliodonium chloride   Fluka   Taufkirschen 
Dimethyl sulphoxide    Roth   Karlsruhe      
Dithiotheitol     ICN    Heidelberg 
ECL detection kit     Amersham  Freiburg 
Ethanol      Roth     Karlsruhe      
Ethylene diamine tetraacetate   Sigma   Taufkirchen 
Formaldehyde      Merck    Darmstadt 
Glycerol       Merck   Darmstadt           
HEPES      Serva   Heidelberg 
Iodixanol (Optiprep™)       Axis-Schield      Oslo, Norway 
Iodoacetamide     Serva   Heidelberg 
Iodonitrophenyl tetrazolium chloride  Sigma   Taufkirchen 
Leupeptin      Boehinger  Manheim 
L-Phenyl alanine     Gibko BRL    Karlsruhe 
Lubrol       Sigma   Taufkirschen    
Magnesium chloride      Baker   Freiburg 
Methionine methyl ester    Sigma   Taufkirschen 
Methylene blue     Fluka   Taufkirschen 
4-Methylumbelliferyl-ß-D-glucosamine   Moscerdam              Netherlands        
Methyl-ß-cyclodextrin      Sigma   Taufkirschen 
NADH            Substrates  Rotterdam 
N-Ethylmaleimide       ICN   Heidelberg                        
Octyl thioglucoside    Calbiochem  Bad Soden            
Octyl glucopyranoside    Calbiochem  Bad Soden 
p-Nitrophenyl-N-acetyl-ß-D-glucosaminide  Sigma   Taufkirschen 
p-Nitrophenyl-ß-D-glucopyranoside  Sigma   Taufkirchen 
p-Nitrophenyl phosphate    Merck   Darmstadt 
Pepstatin A     Sigma   Taufkirchen 
Percoll©      Amersham  Freiburg 
Phenyl methyl sulphonyl fluoride   Merck   Darmstadt 
Phosphatidyl choline (from egg yolk)  Sigma   Taufkirschen                                  
Potassium cyanide    Sigma   Taufkirschen       
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Pitassium sulphate        Sigma         Taufkirschen 
Protein molecular weight marker (Pre-stained) NEB                         Frankfurt                 
Protein molecular weight marker (broad range) Bio-Rad  Munich 
Pyruvate      Sigma   Taufkirchen 
Roti-Blue (colloidal Coomassie blue)  Roth   Karlsruhe 
Sucrose      Roth   Karlsruhe         
Sodium azide     Merck   Darmstadt 
Sodium bicarbonate    Merck   Darmstadt                     
Sodium dodecyl sulphate    Roth   Karlsruhe 
Triethanolamine     Merck   Darmstadt              
Thiourea      Merck   Darmstadt 
Trifluroacetic acid     Sigma   Taufkirschen        
Triton X-100     Merck   Darmstadt   
Trypsin      Promega  Mannheim 
Valinomycin     Sigma   Taufkirchen 
ZFF (Z-Phe-Phe-diazomethyl ketone)                 Bachem                        Heidelberg  
 
      3.1.2 Antibodies 
 
     Table. 3.1: Antibodies used and their dilutions 
 
Antibody Organism Source Dilution 
 
Anti-LAMP-2 
 
Mouse 
(Monoclonal) 
Raised in Prof. Hasilik`s 
laboratory 
 
1: 2000 
 
Anti-CLN2 
 
Rabbit 
Donated by Dr. E Kominami, 
Japan 
 
1: 2000 
 
Anti-NPC1 
 
Rabbit 
Raised in Prof. Hasilik`s 
laboratory 
 
1: 4000 
Anti-V-ATPase 
(Subunit `a`) 
 
Rabbit 
Santa Cruz Biotechnology, 
Heidelberg 
 
1: 1000 
Anti-Mouse IgG 
HRP conjugate) 
 
Goat 
 
Bio-Rad, Munich 
 
1: 8000 
Anti-Rabbit IgG 
(HRP conjugate) 
 
Goat 
 
Bio-Rad, Munich 
 
1: 4000 
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   3.1.3 Apparatus 
   Blotting chamber      TRANS-BLOTR SD Bio-Rad, Munich                
Preparative centrifuge   RC 5B +   Sorvall, Bad Homburg 
  
ELISA-Reader    MRX   Dynatech Laboratories, 
Denkendorf 
Fluorometer    Fluostar Galaxy BMG Labtechnologies, 
                                                              Offenburg 
Gel filtration column    Superdex-200   Amersham Pharmacia     
Liposome extrusion device         LiposoFast     Avestin, Ottawa, Canada 
Maldi-TOF       Reflex III    Bruker Daltonic, Leipzig 
Rotors for cooling centrifuge   GSA     Sorvall, Bad Homburg 
                                 SS 34        Sorvall, Bad Homburg 
Rotors for ultracentrifuge   TV 860    Sorvall, Bad Homburg 
                                 Ti 60      Sorvall, Bad Homburg 
                                   SW 40          Beckman, Munich 
Spectrophotometer     Pharmacia     Freiburg 
Speed-vac      Centrivac     Heraeus, Hanau 
Ultracentrifuges       Combi Plus  Sorvall, Bad Homburg 
                                 L8-70 M     Beckman, Munich 
Tissue homogeniser   T 45   Ultrathurrax                  
 
3.2   Methods   
    
3.2.1   Purification of lysosomal proteins from human placenta 
The lysosomes were isolated from human placenta as per Diettrich et al. (1996). Fresh human 
placentas were collected from local hospitals and were kept on ice until processed. All the 
buffers used were ice-cold. 
 
3.2.1.1  Tissue homogenisation and removal of debris and nuclei 
 Using a sharp knife, the hard tissue of the amniotic sac and the umbilical cord were removed. 
The trophoblastic material thus collected was washed with 0.9 % NaCl for 3 times. The tissue 
was passed in a regular household mincer. After this step, about 300 g of the tissue was mixed 
with 250 ml homogenisation buffer and treated 4 times with a T 45 Ultrathurrax each time for 
5 sec. The post nuclear supernatant was collected by centrifuging 600 ml homogenate in a 
Beckmann JA 10 rotor for 10 min at 4,000 rpm. The latter was then aliquoted into 6 portions 
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each containing 50 ml, to which 4 ml Percoll© solution (I) was underlayed. A centrifugation 
for 15 min at 20,000 rpm was carried out in an SS-34 rotor. After separating from the 
sediment, the organelle concentrates from different tubes were pooled. The pool was made up 
to a total volume of 40 ml with the homogenisation buffer. 
 
Homogenisation buffer:  250 mM   Sucrose 
                                              10 mM     Acetic acid  
                                      10 mM    Triethanolamine 
                                     10 mM    EDTA 
                          pH adjusted to 7.2 with NaOH 
 
65 %  (w/v) Sucrose in homogenisation buffer 
 
Homogenisation buffer-I (1.075 density): 
 
          For 50 ml:            18.87 g    Percoll© in 
                                              250 mM   Sucrose 
                                  10 mM    Acetic acid 
                                        10 mM    Triethanolamine 
                                 10 mM    EDTA 
                  pH adjusted to 7.2 with NaOH 
                   
 Homogenisation buffer-II (1.095 density): 
 
                For 50 ml:   27.56 g   Percoll©  in 
                                                   250 mM   Sucrose 
                                                  10 mM   Acetic acid 
                                          10 mM   Triethanolamine 
        10 mM   EDTA       
     pH adjusted to 7.2 with NaOH         
 
3.2.1.2      Subcellular fractionation 
A self-forming density gradient of polyvinylpyrollidine coated silica particles (Pertoft et al., 
1978) was used for the separation of lysosomes from other sub cellular compartments (Rome 
et al., 1979). Gradients were made in four 35 ml ultra thin tubes made of polyallomer. Step 
gradients were created in each tube with 3 ml 65 %  (w/v) sucrose, 8 ml Percoll© solution (I), 
14 ml Percoll© solution (II), and on the top 10 ml of organelle concentrate was layered. Tubes 
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were sealed tightly as per description, placed in a vertical TV-860 rotor and centrifuged for 30 
min at 21,000 rpm (42000 × gmax). Opening of the tubes was done carefully at the bottom for 
collecting the fractions using a fraction collector. From each tube, 17 fractions of 2 ml were 
collected. All the fractions as well as the post nuclear supernatant were analysed for the 
protein content and marker enzyme activities. Fractions showing the highest specific activities 
of lysosomal markers (2-5) were pooled. The well-mixed dense lysosomal vesicles (`Dense 
pool`) thus prepared were dropped into liquid nitrogen and stored at -80 °C. 
 
  3.2.1.3   Isolation of membranes by ultracentrifugation    
The dense lysosomal vesicles obtained by differential centrifugation in the Percoll© gradient 
was subjected to hypotonic lysis, soluble proteins were washed away, and the membranes 
were sedimented by heavy speed centrifugation for the analyses. Protease inhibitors were 
included to limit the degradation of membrane proteins by the acid hydrolases released during 
the process of vesicle disruption by ultrasonication.               
              
Washing buffer (I):     10 mM        Tris 
                                              pH adjusted to 7.4 with HCl 
 
Table. 3.2: The protease inhibitors and concentrations 
Protease inhibitors  Final concentration Proteases affected 
Iodoacetamide   0.5 mM -SH hydrolases 
Leupeptin   10 µM  Serine and cystine proteases 
Pepstatin A    1 µM  Aspartic proteases 
Phenyl methyl sulphonyl fluoride    1 mM  Serine proteases 
Z-Phe-Phe-diazomethylketone  1  µM  Cathepsins 
 
After thawing the `dense pool` lysosome fraction in an ice bath, protease inhibitors 
were added to make the preferred end concentrations. After ultrasonication for 10 sec, ice 
cold washing buffer (I) was used to dilute the disrupted vesicles to 10 fold for effecting the 
hypotonic lysis. Ultracentrifugation for 2 h at 4 °C was carried out in a Ti-60 rotor at 50,000 
rpm (250,000 × gmax). The pelleted membranes were collected carefully with a pasteur pipette 
and re-suspended in washing buffer for another 10-fold dilution. Repeated the centrifugation 
step, pellets were collected, aliquoted and stored at -70 °C for long-term use. 
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3.2.1.4   Immuno-affinity purification 
Eupergit C1Z beads coupled to the monoclonal antibody (2D5) against lysosomal marker 
protein LAMP-2 was used for the specific enrichment of lysosomes from dense pool fraction 
by immuno- affinity adsorption. Experiments were carried out in 1.5 ml Eppendorf vials, with 
500 µl of dense pool lysosomes for each trial. Protease inhibitors were included in the system 
to get the preferred end concentrations. After sonication for 5 sec, the samples were 
centrifuged in a Jouan-centrifuge for 35 sec to reach the highest acceleration. Undisrupted sub 
cellular compartments, especially a major portion of mitochondria were sedimented by this 
speed. Supernatant obtained was incubated with 40 µl of pre-washed 2D5-Eupergit C1Z 
beads, at 4 °C with an end-to-end rotatory wheel for 4-12 h for maximum binding.  
 
Unbound proteins were removed accordingly by centrifuging in a Jouan-centrifuge 
with 30 sec acceleration at full (12,000 rpm). The pellet was washed gently using 1 ml 
washing buffer followed by another centrifugation for 30 sec. Supernatant was discarded and 
the pellet suspended in 20 µl washing buffer for storage at -20 °C. 
 
   Washing buffer (II):      10 mM           Tris 
                                      150 mM        NaCl 
                                                          pH adjusted to 7.4 with HCl 
      
3.2.1.5     Purification of dense pool by MME treatment 
A substrate induced selective disruption of lysosomes with amino acid esters  (Goldman and 
Kaplan, 1973, Reeves, 1979) was carried out to obtain one more level of purification. 
Methionine methyl ester was found to be the most suitable for placental lysosomes. 
 
Homogenisation buffer:        250 mM        Sucrose 
                                                    10 mM         Acetic acid 
                                        10 mM        Triethanolamine 
                                          5 mM        EDTA 
                                     pH adjusted to 7.5 
 
Substrate:                          100 mM       Methionine methyl ester in  
                                                                             homogenisation buffer 
MgCl2:                               1 M            solution in water 
 
A suspension of 32 ml of dense pool lysosomes was thawed on ice, diluted to 6-8 fold 
and centrifuged using a Ti-60 rotor for 90 min at 35,000 rpm (110,000 × gmax). Sedimented 
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organelles were collected using a pasteur pipette and resuspended in 50 ml homogenisation 
buffer to repeat the centrifugation at 32,000 rpm (100,000 × gmax) for another 60 min. 
Sediment was collected, suspended in 10 ml homogenisation buffer and MME was added to 
get a final concentration of 100 mM. Incubation at room temperature for 40 min was followed 
by addition of required amounts of protease inhibitors for terminating the MME-induced lysis 
and protection from other hydrolases.  
 
  From the lysate obtained after MME treatment, aliquotes of 1 ml were serially pipetted 
in to eppendorf caps to which MgCl2 stock solution was added to get a final concentration of 
10 mM for aggregation of contaminating membranes (Stoner and Sirak, 1978) (Morris et al., 
1979) (Kwan, 1986). The mixture was allowed to stand for 12 h at 4 °C after mixing 
thoroughly. Non-disrupted contaminating organelles were removed by a short step 
centrifugation for 5 min at 4 °C in a Sorvall centrifuge with 11,000 rpm (10,000 × gmax). 
Supernatant obtained containing enriched lysosomal vesicles was sedimented with the help of 
eppendorf adaptors in a Ti-60 rotor at 50,000 rpm (250,000× gmax) for 90 min, and stored at 
-70 °C for further analyses. 
 
3.2.1.6    Separation of membrane complexes by gel filtration 
Gel filtration for separating high molecular weight complexes from the lysosomal membrane 
was performed using a Superdex-200 column (Amersham Pharmacia, Freiburg). Proteins 
from MME treated lysosomal membranes were extracted for 20 min in 200 µl extraction 
buffer at either 4 °C or room temperature with occasional gentle shaking. The detergent 
treated samples were centrifuged for 10 min at 14,000 rpm to remove unsolublilised material. 
From the supernatant obtained, 200 µl was loaded on a 4.6 Χ 150 mm gel filtration column 
connected to an HPLC apparatus with the help of a fine syringe. The flow rate was adjusted to 
250 µl/min and fractions of 250 µl were collected at uniform intervals of time using a fraction 
collector connected to the apparatus. Samples obtained were stored directly at 4 °C or frozen 
for further analyses. 
 
Extraction buffer:              20 mM        Tris-HCl 
                                                 150 mM        NaCl 
                                                      1 % (v/v)        Triton X-100 (reduced) 
                                              0.25 % (w/v)    CHAPS 
                                                          Adjusted to pH 7.5 with HCl  
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Gel filtration buffer:                 20 mM            Tris-HCl 
                                                        150 mM          NaCl 
                                                        0.1 % (v/v)      Triton X-100 (reduced)     
                                        0.025 % (w/v)    CHAPS 
                                                        Adjusted to pH 7.5 with HCl 
 
3.2.1.7  Separation of floating material in Optiprep™ density gradient 
The lysosomal membranes obtained from dense pool after MME-treatment were extracted 
with 450 µl of extraction buffer at 4 °C for 20 min. Sample was centrifuged at a speed of 
14,000 rpm for 10 min at 4 °C and the extract was mixed with 2 volumes of Optiprep™ 
(Veldhoven et al., 1996) for layering on the top of a 60 % (v/v) iodixanol cushion. A step 
gradient of iodixanol was made as mentioned below in a 4.5 ml plastic tube. 
 
 Extraction buffer                     100 mM         Tris-HCl 
                                                           150 mM          NaCl 
                                                          10 mM          EDTA 
                                                      1 %  (w/v)        Triton X-100 
                                                      pH adjusted to 7.4 with HCl                         
 
Table. 3.3: Preparation of the iodixanol gradient 
 
Step Gradient 
(from the top) 
Iodixanol concentration (%) Volume (µl) 
1 
2 
3 
4 
0 
30 
40 
60 
300 
2100 
1350 
500 
 
Centrifugation was done in a SW 60 rotor with adaptors for the plastic tubes that 
contain the sample. For the separation of floating material, 50,000 rpm (250,000 × gmax) for 5 
h was applied. After the centrifugation, fractions of 300 µl were collected carefully from the 
top of the gradient using a yellow pipette tip. 
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3.2.1.8       Assays of enzyme activities 
 
3.2.1.8.1     Assay of N-Acetyl-ß-D-glucosaminidase; EC 3.2.1.52   (von Figura 1977) 
All chemicals including the substrate p-Nitrophenyl-2-acetamido-2-deoxy-ß-D-
glucopyranoside were purchased from Sigma unless otherwise mentioned. 
 
Substrate buffer:            100 mM         Citrate 
                                                    0.2 % (w/v)      Bovine serum albumin 
                                      0.2 % (w/v)      Triton X-100  
                                      0.04 % (w/v)    Sodium azide 
                                                adjusted to pH 4.6 with NaOH. 
 
Substrate solution:          10 mM            p-Nitrophenyl-2-acetamide-2- 
                                                                          deoxy-ß-D-glucoside in substrate  
                                                               buffer 
 
Stop solution:                  0.4 M             Glycine/NaOH, pH 10.4 
 
Microtitre plates were used for the enzymatic assays. Samples to be analysed were 
diluted in 0.9 % NaCl to 25 µl, mixed with an equal volume of the substrate solution and 
incubation was performed for 30 or 60 min at 37 °C. After the addition of 250 µl stopping 
buffer, the extent of p-nitrophenol liberated was measured at 405 nm with the help of a 
microplate ELISA reader. Activity of ß-hexosaminidase was evaluated as  
 
Measured volume x  net absorption 
Absorption coefficient x sample volume x incubation time x path length (1 cm) 
 
3.2.1.8.2   Assay of acid ß-Glucocerebrosidase; EC 3.2.1.45 (Gatt 1969) 
The activity of membrane bound ß-Glucosidase was estimated colorimetrically by following 
the degradation of p-Nitrophenyl-ß-D-glucopyranoside by the enzyme. This was followed by 
measurement of the generated p-nitrophenol at 405 nm. 
 
Substrate solution:                     4 mM           p-Nitrophenyl-ß-D- 
                              glucopyranoside 
                                 0.2 % (v/v)     Triton X- 100 
                                             0.2 % (w/v)   Na-Taurocholate 
                                        0.2 M          Sodium acetate buffer, pH 5.0 
Stop buffer:                  0.4 M          Glycine/NaOH, pH 10.4                   
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Samples in Eppendorf caps were diluted with 0.9 % NaCl to 25 µl, added equal 
volume of the substrate and incubated at 37 °C for 60-120 min and the assay was stopped by 
adding 300 µl stop buffer. The supernatants after centrifugation at 14,000 rpm for 10 min 
were collected in microtitre plates for measuring the absorption at 405 nm. 
 
3.2.1.8.3   Assay of Acetyl-CoA: α-glucosaminide N-acetyl transferase; 
                        EC 2.3.1.78  (Voznyi et al., 1993) 
Acetyl-CoA: α-glucosaminide N-acetyl transferase was measured fluorimetrically using a 
coupled enzyme assay. A fluorogenic substrate, 4-methylumbelliferyl-β-D-N-glucosaminide 
was converted by the enzyme to an N-acetylated intermediate, which was cleaved by an 
externally provided ß-N acetyl glucosaminidase (EC 3.2.1.52). The resulting fluorescent 
product was measured with the use of a fluorometer. 
 
Substrate buffer:           0.25 % (w/v)    Triton X-100 
                                      0.02 %            Sodium azide 
                                             200 mM            Sodium phosphate/100 mM   
                                                   Citrate, pH 5.5 
 
Coenzyme (stock):      100 mM            Acetyl coenzyme A in water 
ß-hexosaminidase (stock):      20 m units          ß-N acetyl glucosaminidase in  
                                                                                     water 
 
Substrate solution:                 3 mM              4-Methylumbelliferyl-alpha-D-N- 
                                                                              Sulphoglucosaminide in buffer 
 
Stop buffer:          0.4 M      Glycine/NaOH, pH 10.4 
 
 
The assay was performed in microtitre plates in a reaction volume of 30 µl. Samples to 
be analysed were diluted with water to 14 µl. The reaction was started by adding 16 µl 
substrate reagent providing final concentrations of 2 mM acetyl CoA, 2 m units ß-N acetyl 
glucosaminidase and 3 mM substrate. After mixing well, samples were incubated at 37 °C up 
to 2 h and the reaction was terminated by adding 70 µl stop buffer. The fluorescence was 
measured at excitation and emission wavelengths of 355 and 460 nm respectively using a 
fluorescence-ELISA-reader. 
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3.2.1.8.4 Assay of placental alkaline phosphatase; EC 3.1.3.1    
PLAP, a DRM-associated protein is mainly localised in the plasma membrane and is probably 
a contamination in the lysosomal preparations. Liberation of p-nitrophenol from p-nitrophenyl 
phosphate by the PLAP was measured at 405 nm using a microplate reader.  
 
Substrate solution:                  5 mM           p-Nitrophenyl phosphate 
                                         250 mM      Sucrose 
                                               5 mM          MgCl2
                                            0.1 % (w/v)    Triton X-100      
                                            50 mM         Tris-HCl, pH 9.0 
                                                                                       
  Samples were diluted in 0.9 % NaCl to 50 µl, and 250 µl of the substrate was pipetted 
in to the wells for incubation at 37 °C. Cleavage of the substrate to p-Nitrophenol was 
observed by the development of yellow colour and was measured accordingly. 
 
3.2.1.8.5   Assay of tripeptidyl peptidase-1; EC 3.4.14.9 (Junaid et al., 2001) 
Lysosomal tripeptidyl peptidase-1 activity was traced by the cleavage of it`s synthetic 
substrate Ala-Ala-Phe-7-amido-4-methyl coumarine by the enzyme so as to generate a 
fluorescent product 7-amino-4-methyl coumarine. 
 
Substrate solution:                   0.25 mM          Ala-Ala-Phe-7-amido-4- 
                                                                               methyl coumarine 
                                                 100 mM           Sodium acetate pH 3.5 
0.1 % (v/v)   Triton X-100 
 
Stop buffer:                              0.4 M         Glycine/NaOH, pH 10.4 
 
Samples were diluted with water to 15 µl and mixed with 15 µl doubly concentrated  
substrate solution to effect production of fluorescent product at room temperature. After an 
incubation period of 20 min the reaction was stopped by the adding 70 µl stop buffer. 
Liberated 7-amino-4-methyl coumarine was measured fluorometrically with an excitation 
maximum at 360 nm and emission at 460 nm. 
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3.2.1.8.6 Assay of succinate dehydrogenase; EC 1.3.5.1 
As a mitochondrial marker enzyme, succinate dehydrogenase was followed on the course of 
purification strategy using a colorimetric system. 
 
Isotonic saline:              150 mM              NaCl  
                           
Substrate mixture:                     122 mM                 Sodium succinate 
                                              61 mM                  Sodium phosphate, pH 7.4 
                                                 0.09 % (w/v)          Iodonitrophenyl tetrazolium 
                                                                                         chloride 
                                                  0.05 % (w/v)        Sodium azide 
Stop solution:                            10 % (w/v)           Trichloroacetic acid 
 
Extraction solution:                   50 % (v/v)             Ethyl acetate 
                                                       50 % (v/v)             Ethanol      
The sample to be assayed was made up to 50 µl with isotonic saline to which 82 µl of 
the freshly made substrate was added. Reaction was allowed to proceed at 37 °C for several 
hours, and terminated by the addition of 150 µl stop solution. The water insoluble end product 
was extracted with 400 µl extraction solution, with thorough vortexing, and centrifuged at 
14,000 rpm for 10 min. In to a 96 well microplate, 300 µl supernatant was pipetted for 
measuring the absorption at 490 nm using an ELISA plate reader.        
        
3.2.1.8.7  Assay of inorganic phosphate 
ATPase activity of lysosomal preparations were measured using the conventional inorganic 
phosphate assay. Degradation of ATP by the enzyme was followed by coupling of generated 
inorganic phosphate to ammonium molybdate. The resultant coloured complex was measured 
at 630 nm using a regular colorimeter. 
 
Substrate (stock):                100 mM          Adenosine triphosphate-Na salt 
Substrate buffer:                         25 mM          HEPES, pH 7.5 
                                                 25 mM      KCl 
                                                 5 mM            MgCl2
                                                            5 mM            KCN 
                                          
Coupling solution:                         0.5 %  (w/v)     Ammonium molybdate in 0.7 N    
                                                                                       H2SO4
Anti-oxidant:                            10 % (w/v)       Ascorbic acid 
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ATPase assay was carried out in 1.5 ml eppendorpf vials at 37 °C with 200 µM ATP 
as the substrate. Samples to be analysed were diluted with water to 50 µl and added 50 µl 
sample buffer containing the prescribed amount of ATP. Reaction was terminated after 2-4 h 
by heating the sample for 30 sec at 95 °C. Care was taken to make sure that heating doesn’t 
effect in ATP degradation. Samples were allowed to cool down, centrifuged for 1 min at 2000 
rpm at 4 °C and added 42 µl coupling solution. To prevent oxidation of the complex, 8 µl of 
10 % ascorbic acid was added and mixed thoroughly. Heated at 95 °C for 90 sec and the 
absorbance were measured at 630 nm after transferring in to a micro titre plate. Vacuolar 
ATPase activity corresponding to the lysosomes was calculated by the extent of inhibition of 
ATP hydrolysis using N-ethyl maleimide or bafilomycin-A1 as specific inhibitors of vacuolar 
ATPase. Trace amounts of detergents in the sample, especially NP-40 and Triton X-100 
resulted in turbidity of the coloured complex, which was efficiently removed by mixing the 
complex with equal amount of chloroform followed by its removal after a centrifugation. 
Controls were maintained to assure that, this process does not affect either the stability of the 
complex or the optical density. 
3.2.1.9   Estimation of total protein by Bradford method 
Protein concentration was determined by the method by Bradford (1976) using bovine serum 
albumin as the standard. Samples were diluted in 0.25 M NaOH/0.025 % (v/v) Triton X-100 
for the solubilisation of membrane proteins and centrifuged for 10 min. From the supernatant, 
20 µl was used for the estimation of protein. The absorbance was measured at 595 nm in a 
microtitre plate, after adding 300 µl Bradford reagent to the sample. 
 
3.2.1.10  SDS-PAGE 
For sample characterisation, proteins in the purified lysosomal fractions were separated by    
SDS-PAGE according to Laemmli (1970) with modifications as described below. A range of 
proteins with molecular weights was used as standards from Myosin (200 kDa) to Aprotinin 
(8.5 kDa). Solubilisation buffer containing the anionic detergent sodium dodecyl sulphate was 
used for extraction and denaturation of the proteins, which were then separated on a 
polyacrylamide gel on the based on molecular weight.  
 
3.2.1.10.1  Preparation of acrylamide gels 
Gels with a thickness of up to 1mm, length 13.5 cm and width 14 cm were used for the 
separation. Plastic combs with 20, 22 or 33 wells were used. Gels were casted with a low 
percentage stacking gel on the top, which makes the migration of proteins easy and sharp 
followed, by higher percentage gel for the adequate separation of proteins. Gels were stable at 
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4 °C up to 1 week in a plastic sheet. The top and bottom of the gels were kept wet for the gel 
not to dry or broken. 
Table. 3.4: Gel solutions 
 
Stacking gel                                                                 Final acrylamide concentration 
Acrylamide (% (w/v)) 3 % 4.8 % 
N,N`-Methylene bisacrylamide (% (w/v)) 0.11 % 
Tris-HCl, pH 8.8 0.125 M 
Sodium dodecyl sulphate 0.1 % (w/v) 
TEMED 0.1 % (v/v) 
APS 0.1 % (w/v) 
 
 Separation gel                                                          Final acrylamide concentration 
Percentage 8,1 % 10.7 % 12.6 % 15.2 % 
Acrylamide (% (w/v)) 8 % 10.6 % 12.5 % 15 % 
N,N`-Methylene bisacrylamide (% (w/v)) 0.08 % 0.11 % 0.13 % 0.16 % 
Tris-HCl, pH 8.8                                  0.375 M 
Sodium dodecyl sulphate                                  0.1 % (w/v) 
TEMED                                  0.1 % (v/v) 
APS                                0.1 %  (w/v) 
 
Separation gel overlay buffer:  0.375 M  Tris-HCl, pH 8.8 
50 % (w/v)  Isopropanol 
 
Stacking gel overlay buffer:   0.125 M  Tris-HCl, pH 6.8 
0.1 % (w/v)  SDS 
 
Glass plates were washed repeatedly with millipore water and ethanol. A spacer was 
used between the glass plates and the plates were stuck together using a clamp. Separation gel 
mixture was prepared and poured in between the glass plates carefully without any air bubbles 
and separation gel overlay was applied on the top. After 30 min, the overlay was washed off. 
A filter paper was used to remove the water. The stacking gel mixture was prepared 
meanwhile and poured on the top of the separation gel and well combs were inserted. The 
polymerisation was completed within 30 min after which the gel was either used fresh or 
stored. 
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3.2.1.10.2     Sample preparation 
Samples containing the proteins to be separated were mixed with sample buffer in 1:1 ratio 
with the end volume being not more than 30 µl. Samples in the form of pelleted proteins were 
solubilised with 1X solubilisation buffer. After the addition of solubiliser, samples were kept 
at 37 °C with gentle shaking. Iodoacetamide was added to a final concentration of about  
75 mM for carbamidomethylation of the reduced proteins and incubated for another 15 min at 
37 °C. A centrifugation was carried out to sediment insoluble aggregates at 14,000 rpm for 5 
min. 
 2X Solubilisation buffer:            2 % (w/v)           SDS 
                                                  20 mM                Dithiothreitol   
                                     0.25 M              Tris-HCl, pH 6.8 
                                                 20 % (v/v)          Glycerol 
   
3.2.1.10.3   Electrophoresis 
All the buffers were stored at 4 °C. For one trial of electrophoresis, 5 litres of anode buffer 
and 250 ml cathode buffer were required. Electrophoresis was performed at 15 mA/gel during 
the migration though the stacking gel, and at 30 mA once it reached the separation gel. 
Bromophenol blue in the sample as well as cathode buffer migrated just behind the salt 
boundary and marked end of the separation after approximately 3.5 h. 
 
Cathode buffer:                        384 mM                 Glycine 
                                                     23 mM                 Tris 
                                                      0.01 % (w/v)          SDS 
                                                      0.001 % (w/v)           Bromophenol blue 
 
Anode buffer:                               384 mM               Glycine  
                                                         23 mM              Tris    
 
3.2.1.10.4    Staining of proteins by silver nitrate (modified from Heukeshoven, 1988) 
Proteins on the analytical scale were visualised by silver staining method due to its sensitivity, 
rapidity and easiness in handling.  
 
Fixative:                                  30 % (v/v)      Ethanol 
                                              10 % (v/v)        Acetic Acid 
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Thiosulphate solution:               0.1 M             Sodium acetate, pH 6  
                                                      30 % (v/v)        Ethanol  
                                             0.1 % (w/v)     Sodium thiosulphate 
                                     (used for one dimensional analyses) 
                                                  0.2 % (w/v)      Sodium thiosulphate 
                                               (used in two dimensional analyses) 
Silver nitrate solution:             0.1 % (w/v)      Silver nitrate   
                                        0.01 % (w/v)    Formaldehyde 
 
Developer:                   2.5 % (w/v)     Sodium carbonate     
                                                    0.02 % (w/v)    Formaldehyde 
 
Incubations for silver staining were done at room temperature in cleaned glass trays 
with continuous gentle shaking. For each step 100 ml solution was used. To start with, the gel 
was kept in fixative for 30 min, followed by another 30 min incubation in thiosulphate 
solution. In the case of two-dimensional gels 0.2 % thiosulphate solution was used with an 
extended incubation to over night for the better staining. Gels were washed 3 times each for 
10 min and kept in silver nitrate solution for 25 min. Formaldehyde was added to the silver 
nitrate solution as well as developer just before it being applied to the gel. After a short 
washing step for 30 sec, 100 ml developer solution was used for staining. Once the protein 
signals were visible, 7-8 ml concentrated acetic acid was dropped into the tray so as to stop 
the staining procedure. Gels can be washed and stored after drying in between two layers of 
cellophane membrane. 
 
3.2.1.10.5 Coomassie staining of proteins 
Protein staining with colloidal Coomassie blue solution was applied in the case of preparative 
gels, as silver staining is not compatible with mass spectrometry normally though otherwise  
reported.  
 
Fixative:                        1 % (v/v)      o-Phosphoric acid 85 % (w/v) 
                                              20 % (w/v)     Methanol 
 
Dye solution:                            20 % (v/v)     Roti-blue (concentrate) 
                                                 20 % (v/v)     Methanol 
Washing:                         25 % (v/v)      Methanol 
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The gel was incubated in the fixative solution (100 ml/gel) for 1 h. Freshly prepared 
dye solution was added to the gel for overnight incubation. Next day, the gel was transferred 
to a new clean glass tray for washing with 25 % methanol 3 times, each spanning 2 min. 
Washing step allows the elimination of unspecific binding of dye in order to decrease the 
background for better visualisation. Gel was kept in deionised water for storage at cold. 
 
3.2.1.11   Two-dimensional electrophoresis (O` Farrell, 1975) 
Two-dimensional electrophoresis (2DE) was performed with isoelectric focusing using carrier 
ampholytes for the first dimensional separation of proteins based on their isoelctric points and 
with SDS-PAGE for the separation in second dimension.  
 
3.2.1.11.1   Isoelectric focusing of proteins 
Glass tubes (16 X 3.1 mm inner diameter) were used for casting the tube gels for isoelectric 
focusing. The bottom end of the tube was sealed tightly with parafilm and a mark was made at 
12.5 cm from this end. Composition of the tube gel varied with the kind of detergent system 
used for solubilisation of membrane proteins.  
 
Acrylamide solution:           28.4 % (w/v)  Acrylamide 
                                                      0.8 % (w/v)     N, N`-Methylene bisacrylamide   
Sample overlay:                                 7 M               Urea 
                                                                             
                                                      0.8 % (v/v)    40 % (w/v)  Ampholytes, pH 4-7  
                                                        0.2 % (v/v)    40 % (w/v) Ampholytes, pH 3-10 
             
Cathode electrolyte:              200 mM       NaOH 
 
Anode electrolyte:                            100 mM         H3PO4      
 
3.2.1.11.2   Urea/CHAPS gel and solubilisation system   
 Composition of one capillary gel  
                             0.48 gm    Urea 
                                    107 µl    40 % (w/v) Ampholytes, pH 4-7 
                                  27  µl     40 % (w/v) Ampholytes, pH 3-10 
                                143 µl     Acrylamide solution 
                                 107 µl    20 % (w/v) CHAPS 
                                    357 µl    de-ionised water 
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The gel mixture was degassed for 10 min followed by addition of 0.4 µl TEMED and 
8 µl of 10 % (w/v) APS for the polymerisation to be induced. A long Pasteur pipette was used 
for transferring the gel mix to the already prepared clean capillary tubes up to the 12.5 cm 
marking. 130 µl of 6.5 M Urea solution was used as an overlay and allowed to stand at room 
temperature for 1 h to commence complete polymerisation. Capillary gels thus made were 
stored at 4 °C for a maximum period of 2 weeks.  
 
       Protein samples were solubilised in the lysis buffer containing urea and CHAPS at 37 °C. 
Composition of the lysis buffer was as follows. 
 
9M     Urea 
                            4 % (w/v)        CHAPS 
                                2 % (v/v)      40 % (w/v) Ampholytes, pH 4-7 
                           0.5 % (v/v)       40 % (w/v) Ampholytes, pH 3-10 
                               10 mM               Dithiotheitol 
 
Protein samples were used either directly (≤ 20 µl) or after a precipitation with 4 
volumes of cold acetone when a large volume was to be used. They were dissolved in 100 µl 
lysis buffer and incubated at 37 °C for 2 h. A centrifugation was carried out for 10 min prior 
to loading the solubilised proteins on the capillary gel.       
                            
3.2.1.11.3 Thiourea/ASB 14 gel and solubilisation system 
Inclusion of thiourea in the isoelectric focusing system together with urea and substitution of 
CHAPS with ASB-14 is reported to be better for either the solubilisation and resolution of 
membrane proteins (Shaw and Riederer, 2003). Instead of TEMED and APS-induced 
polymerisation of the acrylamide in capillary gel, a photopolymerisation with methylene blue 
in presence of sodium toluene sulphinate and diphenyliodonium chloride was applied as the 
former strategy being not compatible with thiourea.  
 
Thiourea considerably increases the solubilisation of hydrophobic membrane proteins, 
though it has the disadvantage that at a pH range of 8.5-9 during the equilibration step, the 
sulphur atom of thiourea is highly reactive and consumes the iodoacetamide resulting in poor 
alkylation of proteins. 
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Composition of one capillary gel is given in the table below. 
                   Urea                       6 M 
                     Thiourea             2 M  
                   40 % (w/v) Ampholytes, pH 3-7     10.2 % (v/v)   
                    40 % (w/v) Ampholytes, pH 3-10    2.6 % (v/v)  
                       Acrylamide                                    4.1 % (w/v) 
                       N, N´-Methylene bisacrylamide   0.11 % (w/v)        
                       ASB-14                    2 % (w/v) 
                    Triton X-100      0.5 % (w/v) 
The gel mix was degassed for 10 min. Photo polymerising agents were then added to obtain 
the following end concentrations. 
 
                      Sodium-p-toluene sulfinate              500 µM 
        Diphenyliodonium chloride  25 µM 
                      Methylene blue                50 µM  
      
The gel mixture for polymerisation was filled into the capillary tubes as in the case of 
urea/ CHAPS system and was hung in a vertical upright position with a source of visible light 
kept as close as 35 cm from the capillary tubes for inducing photo polymerisation. For 
complete polymerisation, 12 h were sufficient after which gels were stored at 4 °C up to 2 
weeks. 
 
The composition of the solubilisation buffer was 
 
              6 M                   Urea    
                               2 M                    Thiourea 
                               2 % (w/v)     ASB-14 
                            0.5 % (w/v)     Triton X-100  
                         2.5 % (v/v)     40 % Ampholytes, pH 7-9 
                             10 mM              DTT            
                 
The sample solubilisation of proteins with this buffer was carried out as described for the 
urea/CHAPS system (3.2.1.9.3). 
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3.2.1.11.4  Performing isoelectric focusing 
The capillary gels were allowed to thaw to the room temperature, overlayed sequentially with 
100 µl corresponding lysis buffer and 50 µl de-ionised water. After 1 h at room temperature, 
the bottom sealing of the gel was replaced by a dialysis membrane stabilised by a rubber ring. 
The solubilised samples were loaded on to the equilibrated capillary gel and overlayed with 
20 µl sample overlay containing 7 M urea. Before starting the isoelectric focusing, the tubes 
were filled with cathode buffer avoiding air bubble trapping. 
 
In the bottom buffer reservoir, 4.5 L of 0.01M H3PO4 was filled and 1.25 L of 0.02 M 
NaOH was poured in to the upper cathode chamber. With the urea/CHAPS and thiourea/ASB-
14 systems temperature was maintained at 4 °C and 37 °C respectively. 
 
Table. 3.5: The voltage settings during isoelectric focusing 
 
      Step                           Voltage (V)                  Duration (h)           
           
          1                         200                              0.5         
          2                             750                              15.5 
          3                              850                              1  
          4                             1000                            4      
In both systems, the voltage settings were as described in Table. 3.5 
 
3.2.1.11.5  Equilibration prior to the second dimension SDS-PAGE 
After the completion of isoelectric focusing, the gels were displaced using a plastic syringe 
filled with water in to a small dish. Maximum care was taken while pressing out the gels from 
the tubes to avoid breaking. The alkaline end of the gel was marked with 10 % (w/v) 
bromophenol blue.  
 
25 ml equilibration buffer I and II (see below) were used for the urea/CHAPS system 
each for 30 min at 37 °C respectively with gentle shaking. For thiourea/ASB-14 system, first 
equilibration with buffer I was carried out at 37 °C followed by a second equilibration with 
the same buffer at 50 °C. The step was repeated with equilibration buffer III for 2 times at 
50 °C each with 25 ml fresh buffer, which was pre-incubated at the same temperature. 
Equilibration buffer I          0.05 M        Tris-HCl, pH 6.8 
          4 % (w/v)            SDS 
                                        0.25 % (w/v)    DTT 
                                                 15 % (w/v)    Glycerol 
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Equilibration buffer II             0.05 M        Tris-HCl, pH 6.8 
                                                    4 % (w/v)      SDS 
                                                 25 mM            Iodo acetamide 
                                                  30 % (w/v)    Glycerol 
                                                     6 M                  Urea    
 
Equilibration buffer III        0.05 M     Tris-HCl, pH 6.8 
                                                  4 % (w/v)     SDS 
                                 25 mM         Iodo acetamide                               
                                               30 % (w/v)       Glycerol 
 
3.2.1.11.6 The second dimension SDS-PAGE 
 
An SDS-polyacrylamide gel was overlaid with 500 µl of warm molten agarose solution for 
fixing the capillary gels. An equilibrated capillary gel was transferred to a cellophane sheet, 
and the liquid was sucked out. The blotted tube gel was placed on the top of the SDS-
acrylamide gel with the alkaline side on the right end and overlaid with molten agarose.  
 
Agarose solution           0.5 % (w/v)      Agarose             
                                       125 mM            Tris-HCl, pH 6.8 
                                             0.1 % (w/v)         SDS     
 
Once the gel is placed, a second layer of agarose was applied on the top of it, and any 
air bubbles were removed. After standing at room temperature for 10 min molecular weight 
standards were introduced. The separation was started at an electric current of 15 mA per gel. 
The current was raised to 30 mA per gel once the bromophenol blue reached the separation 
gel. The run was stopped when bromophenol blue band reached 2 mm from the bottom end of 
the gel. The gels containing 20-40 µg proteins were stained with silver nitrate whereas those 
with 200-400 µg were stained with colloidal Coomassie blue. 
 
3.2.1.12  CETAB-Diagonal electrophoresis (CETAB/SDS-PAGE) 
A cationic detergent, CETAB (Cetyltrimethylammonium bromide) at an acidic pH was used 
for the solubilisation and separation of proteins in the first dimension followed by SDS-PAGE 
in the second dimension (Penin et al, 1984). The gels were casted as before (3.2.1.10.1). For 
the separation, an 8 % gel was used that decreased the duration of separation. 
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Table. 3.6: The gel composition for CETAB electrophoresis 
  
Components 
Stacking gel 
(pH 5.1) 
Separation gel 
(pH 4.0) 
Acrylamide 
N,N´-Methylene bis acrylamide 
KOH 
Acetic acid 
Urea 
CETAB 
Ascorbic acid 
FeSO4
H2O2
4 % (w/v) 
0.34 % (w/v) 
64 mM 
94 mM 
6 M 
0.1 % (w/v) 
4 mM 
4.25 µM 
0.0015 % 
7.5 % (w/v) 
0.26 % (w/v) 
43 mM 
280 mM 
 6 M 
0.1  % (w/v) 
4 mM 
8 µM 
0.001 % 
 
Stacking gel buffer:                 43 mM            KOH 
                                                    280 mM            Acetic acid 
                                                     0.1 % (w/v)      CETAB 
                                                   50 % (w/v)       Isopropanol  
 
Separation gel buffer:                 64 mM              KOH 
                                                       94 mM             Acetic acid 
                                                        0.1 % (w/v)      CETAB 
 
1.5 X Solubilisation buffer (pH 5.1)  4.5 M                    Urea 
                                                            1.5 % (w/v)          CETAB   
                                                         96 mM                 KOH 
                                                         141 mM             Acetic acid 
                                                     15 mM               DTT 
                                                 7.5 % (v/v)         Glycerol 
                                             0.01 % (w/v)      Pyronin Y    
 
Samples were diluted with water to 15 µl and mixed with 30 µl of 1.5X solubilisation 
buffer to obtain 45 µl for loading. For solubilising the membrane pellets, 1X buffer was 
prepared by diluting the stock buffer and effective solubilisation was achieved at 60 °C when 
incubated for 5 min. The solubilised material was subjected to a centrifugation for 5 min at 
14,000 rpm to remove aggregates and undissolved debris.  
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Anode buffer for CETAB electrophoresis (pH 4.0)   40 mM       ß-Alanine 
                                                                                70 mM           Acetic acid                                     
                                                                           0.1 % (w/v)     CETAB 
 
Cathode buffer (pH 5.7)                                 50 mM             KOH 
                                                                                56 mM            Acetic acid     
 
The anode and cathode buffer chambers were filled with 250 ml and 5 L of the 
corresponding buffers, respectively. Buffers used were pre-warmed to 25 °C to avoid 
precipitation of CETAB. Electrophoresis was started at a current of 10 mA per gel and 
continued at 20 mA once the dye front reached the separation gel.  
 
After the CETAB electrophoresis, the sample lanes were cut out using a sharp blade 
and incubated in 25 ml equilibration buffers I and III each for 20 min at 37 °C. The strips 
were transferred on top of the second dimension gel as mentioned previously using pre-
molten agarose for fixing the strip in between the glass plates on the top of the SDS 
polyacrylamide gel. For the migration of proteins in the stacking gel zone, 15 mA was applied 
which was increased accordingly to 30 mA once the dye front reached the separation gel. 
Samples were stained with either silver nitrate (20-40 µg protein) or using colloidal 
Coomassie blue (200-400 µg protein). 
 
3.2.2   Identification of proteins   
The samples were characterised either by western blotting using specific antibodies or by 
mass spectrometric analyses of the tryptic peptides. 
 
3.2.2.1  Western blotting 
Samples to be analysed by Western blotting were first separated on an SDS-PAGE. Low 
percentage gels (8 %) were mostly used for separating high molecular weight proteins as it 
enables the easy migration. This also enables a better transfer of proteins. Once the run was 
completed, gel was equilibrated with washing buffer for 20 min while shaken. 
 
A PVDF membrane soaked in methanol was equilibrated with the washing buffer. 
Two pairs of blotting paper with the size of the gel were soaked, in the anode buffer and the 
cathode buffer for 20 min respectively. A semi-dry blotting chamber was used. The anode 
platform wet with anode buffer and two blotting papers soaked in anode buffer were gradually 
descended to avoid any trapping of air bubbles. This was followed by the soaked PVDF 
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membrane, the gel and the wet cathode blotting papers. A test tube was rolled over the layers 
to remove the excess liquid. The blotting was performed at 1 mA/cm2 for 2 h at 4 °C. After 
the run all the lanes and the corners of the gel as well as dye front were marked with a 
ballpoint pen.  
 
Along with the samples for Western blotting, molecular weight markers that are either 
pre- stained or of broad range molecular weights in sufficient amounts for Coomassie blue 
staining were used. These lanes were cut out and either dried or developed with Coomassie 
staining respectively.       
 
The labelled PVDF membrane was placed in blocking buffer containing ovalbumin for 
at least 2 h at room temperature or overnight at 4 °C in order to saturate the binding sites and 
to decrease unspecific binding of the immunoglobulins. 
 
Washing buffer (W.B.):                     23 mM       Tris 
                                            384 mM      Glycine 
Anode buffer:                      40 mM        ε-Amino caproic acid 
                                                192 mM         Glycine  
 
Cathode buffer:                        25 mM        Tris 
                                             192 mM         Glycine 
    
Blocking buffer:                    7 % (w/v)         Skimmed milk powder in W.B. 
 
After blocking for at least 4 h at room temperature, the buffer was replaced with a new 
aliquot containing the primary antibody. Different dilutions were used as specified before 
(3.1.2). The binding was allowed to take place for 2 h at room temperature or overnight at  
4 °C. The excess antibody was washed away using the wash buffer and then with the wash 
buffer containing 0.1 % Triton X-100. This was repeated for 3 times with each solution. The 
secondary antibody an HRP conjugate diluted in the blocking buffer was poured on the 
washed membrane and incubation was performed for another 2 h at room temperature. The 
washing was repeated. 
                          
ECL detection kit (ECL Plus, Amersham, Freiburg) was used to develop the blot. The 
PVDF membrane was kept on a thin layer of plastic on the top of which ECL mixture was 
poured and spread uniformly. Within 2 min, the blot was transferred in to a cassette and 
exposed to a photographic film (Kodak D-19, Kodak, Paris) for a specified time. The film was 
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placed in a developer solution, fixed in acidofix (Agfa, Leverkusen) for 5 min, and was dried 
in air. 
 
3.2.2.2   Identification of proteins by mass spectrometry 
Mass spectrometry was performed on tryptic digests of proteins. Samples containing the 
proteins to be analysed were separated on polyacrylamide gels and stained with colloidal 
Coomassie blue. Protein spots were cut out from the gels using a capillary device of 1.5 mm 
diameter. Prior to the digestion with trypsin, gel pieces were washed with different solutions 
at 37 °C each time for 30 min as described below. 
 
Table. 3.7: The washing steps of gel pieces prior to tryptic digestion 
 
          Step  Solution 
1 
2 
3 
4 
5 
 Distilled water 
 25 mM NH4CO3
 25 mM NH4CO3/50 % (w/v) acetonitrile 
 25 mM NH4CO3/50 % (v/v) acetonitrile 
 Acetonitrile 
 
Each time, washing was performed with 100 µl of the solution with gentle shaking of 
the vials. After the final acetonitrile washing, gel pieces were kept at room temperature for 5 
min to remove all the organic solvents. 
 
Trypsin stock solution           0.5 µg/µl in 0.01 % TFA/water        (stored at -20 °C)     
 
Working solution            20 ng/µl in 25 mM NH4CO3/water  (made fresh from  
                                                                                                                     the stock every time)                         
 
The dried gel pieces were soaked in 6 µl diluted trypsin (total 120 ng) solution on ice. 
After swelling for 15 min, the digestion was performed at 37 °C for 12 h. The bottom of the 
tube was pierced with a syringe for collecting the peptides by a short centrifugation within a 
larger vial. The gel pieces were incubated for 20 min with 20µl TFA/water mixture and the 
centrifugation was repeated. The combined extracts were dried completely in a vacuum 
concentrator. 
 
For the identification of proteins, Matrix Assisted Laser Desorption Ionisation-Time of 
flight spectroscopy was carried out with the help of Dr. Bernhard Schmidt at Max Planck 
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Institute for Biophysics- Goettingen. Spectral data obtained were processed with the help of 
Bruker X tof 5.1.1 programme in our laboratory. Spectral peak obtained from trypsin peptide 
at 842.51 was used as an internal control for calibrating the sample signals. The analysis of 
evaluated data was performed by Mascot analysis tools (http://www.matrixscience.com) with 
defined modifications. A peptide tolerance of 0.1 Da was kept normally during the search 
with carbamidomethylation and methionine oxidation being the user defined modifications.  
 
3.2.3  Reconstitution of proteins 
Reconstitution of proteins was performed for the enzymatic characterisation and transport 
studies.  
 
Liposome buffer:   20 mM     HEPES, pH 7.4 
     1 mM    EDTA 
     120 mM  K2SO4 
 
Triton X-100 (stock):   20 % (w/v)    in liposome buffer 
 
Bio Beads SM-2   
 
3.2.3.1  Preparation of liposomes 
Triton X-100 solubilised proteins were incorporated in to detergent-saturated liposomes 
(Paternostre et al., 1988). For the preparation of liposomes, egg yolk lecithin and cholesterol 
were used. Egg yolk lecithin (50 mg) and cholesterol (11.25 mg) were solubilised in 
chloroform and the organic solvent was later evaporated under a stream of nitrogen. The 
material remaining was dried under vacuum for 30 min and the lipid film obtained was re-
dissolved in 3 ml of diethyl ether. To the mixture, 1 ml of the liposome buffer was added and 
sonicated for 2 min at 4 °C. Removal of diethyl ether was performed under a steam of 
nitrogen. Normally, 15 min are required for the formation of multilamellar vesicles. After 
addition of further 2 ml of liposome buffer, evaporation of the organic solvent was continued 
for another 30 min. An extrusion device, LiposoFast (Avestin, Ottawa, Canada) was used for 
the preparation of unilamellar vesicles (MacDonald et al., 1991) of about 100 nm diameters. 
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3.2.3.2  Solubilisation of proteins and reconstitution 
Proteins to be reconstituted were extracted with a final concentration of 0.5 % Triton X-100. 
The membrane pellets were extracted with 100 µl liposome buffer containing 0.5 % Triton 
X-100 with occasional vortexing for 30 min at 4 °C. The sample was centrifuged for 10 min 
at 14,000 rpm at 4 °C to remove insoluble material. Supernatant obtained was used for 
reconstitution. The molar ratio of phospholipid to protein was maintained at 8000 mol/mol 
corresponding to 80:1 (w/w) for a 100 kDa protein (Rigaud and Levy, 2003). The protein 
extract was mixed with a corresponding amount of freshly prepared liposomes and mixed by 
vortexing for 5-10 sec. The sample was allowed to stand on ice for 60 min with vortexing 
for5-10 sec after every 20 min. 
 
SM-2 Bio Beads were used (10 g dry beads/g of Triton X-100) for the slow removal of 
detergents to obtain proteoliposomes. The beads were washed 3 times with methanol, 3 times 
with water and finally with liposome buffer prior to its addition to the sample. The beads were 
added to the protein-lipid mixture in 4 equal portions and incubated on ice for at least 2 h per 
every addition (Rigaud et al., 1995).  
 
Beads were spun down from the sample with a short centrifugation for 10 sec. The 
resulting supernatant was centrifuged at 14,000 rpm for 15 min at 4 °C to remove insoluble 
material. Proteoliposomes were collected by ultracentrifugation at 4 °C for 60 min with a 
speed of 50,000 rpm in a Ti 60 rotor. The proteoliposomes obtained were suspended in a 
volume of 100 µl, stored on ice and analysed within 7-10 days. 
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4   Results 
 
4.1    Purification of lysosomes 
 
4.1.1   Isolation of lysosomal membrane by ultracentrifugation 
For conducting a biochemical study of the lysosomal membrane complexes, several strategies 
were adopted to purify placental lysosomes. Purification of human lysosomes was done from 
placental preparations since the availability of tissue was met from the local hospitals. 
Centrifugation on a Percoll® density gradient for isolating dense lysosomal vesicles- the 
`dense pool` (DP) was already standardised in the laboratory (Diettrich et al., 1996). In every 
preparation (Fig. 4.1), specific marker enzymes, membrane bound ß-glucosidase for the 
lysosomal membrane and ß-hexosaminidase for the matrix were followed and protein pattern 
analysed by two-dimensional electrophoresis (2DE). Comparison of specific activities showed 
a 50-55-fold enrichment of lysosomal vesicles through this procedure. 
 7pH 4 
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Fig. 4.1: Two-dimensional separation of the dense pool lysosomal
fraction. The proteins (20 µg) from dense pool fraction of the percoll® gradient
were solubilised in lysis buffer containing urea and CHAPS. Isoelectric
focusing was performed for 20 h followed by separation of proteins on a 15 %
SDS-PAGE. The polypeptides were stained using silver nitrate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The lysosomal membranes (`UC membranes`) were prepared from the dense pool 
lysosomes by ultracentrifugation at 250,000 × gmax after a hypotonic lysis (see 3.2.1.3). The 
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soluble proteins of the lysosomal matrix were recovered in the `UC supernatant` fraction. The 
pellet prepared by ultracentrifugation contained approximately 40 % of the initial protein was 
enriched in lysosomal membrane proteins as indicated by an average 1.5 fold increase (n=3) 
in the specific activity of the non-integrated membrane bound ß-glucosidase (Table.4.1). 
 
Table: 4.1: Enrichment of lysosomal membrane proteins by ultracentrifugation  
Material Volume 
(ml) 
Protein 
(mg/ml) 
ß-glucosidase 
(mU/mg) 
ß-hexosaminidase 
    (mU/mg) 
Dense pool 32 1.53+/-0.28 15.5+/-2.4 1361+/-26.5 
UC membrane 1 20+/-8.5 23.5+/-7.8 233+/-17 
UC Supernatant 200 0.11+/-0.05 5.2+/-0.5 2295+/-21.4 
 
            A specific enrichment of lysosomal membrane proteins in the `UC membrane` fraction 
was indicated on comparison of Fig. 4.2 with Fig. 4.1. The intensities of lysosomal marker 
proteins LAMP-2, LIMP-2 and ß-glucosidase were enriched by the ultracentrifugation step. 
Interestingly, a tentatively lysosomal matrix protein TPP-1 (Hoffmann et al., 2002) was co-
sedimented with the membrane fraction suggesting a probable membrane interaction of this 
protein. The lysosomal membranes enriched in resident membrane proteins (Fig. 4.2) 
obtained were used for the initial experiments where purity was not the primary concern. 
 
Monoamine oxidase
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Fig. 4.2: Two-dimensional separation of ultracentrifuged lysosomal
membrane proteins.  UC membrane proteins were (20 µg) solubilised in
lysis buffer containing urea and CHAPS. After isoelectric focusing for 20 h,
proteins were separated in second dimension on a 15 % acrylamide gel
and stained with silver nitrate. 
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The Percoll® that usually interfere with protein solubilisation and recognition of 
proteins by antibodies, was partly removed by this centrifugal step. The high-speed 
centrifugation resulted in the sedimentation of the membranes present in the sample on the top 
of a lucid Percoll® layer. Mass spectrometric analysis showed a contamination with 
mitochondrial proteins including monoamine oxidase, ATP synthase as well as a few proteins 
of plasma membrane or endoplasmic reticulum localisation (Dr. Buttgereit, personal 
communication). The lysosomes contribute to a small percentage of the cell contents. A small 
fraction of mitochondria co-sedimenting with lysosomes was sufficient to mask the lysosomal 
proteins of low abundance at later stages of analyses. This made further steps in the 
purification of lysosomes mandatory. 
                                                                          
Several strategies were adopted to solve this problem. Attempts to purify the 
lysosomes from the dense pool using an immobilised antibody against the lysosomal 
membrane protein LAMP-2 (see 4.1.2) and alternatively a substrate-induced lysis of the 
lysosomes in combination with centrifugation (see 4.1.3) yielded good results.  Several of the 
other strategies adopted were not efficient in purification and are not described. 
   
4.1.2  Immuno-affinity purification of lysosomes 
Since the lysosomal membrane protein LAMP-2 is expressed in high abundance, a 
monoclonal antibody raised against the luminal tail of this protein was used for the specific 
purification of the lysosomal vesicles from the DP. The antibodies were covalently coupled 
on the surface of Eupergit C1Z beads to perform immuno-affinity adsorption (see 3.2.1.4) 
after disrupting the lysosomes by sonication. The lysosomal vesicles thus produced allowed 
the binding of antibody to LAMP-2. 
 
The DP lysosomes were ultrasonicated and a short-step centrifugation was performed 
prior to the incubation with the immuno-affinity beads. This centrifugation resulted in the 
sedimentation of aggregates (pellet) and intact organelles, mainly the contaminating 
mitochondria (Fig. 4.3). Most of the lysosomal proteins were not sedimented by this 
centrifugation suggesting a considerable enrichment of lysosomes by this step.  
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Marker enzymes for the lysosomal compartment- the membrane bound ß-glucosidase 
(Table. 4.2) and membrane integrated acetyl-CoA:α-glucosaminide N-acetyltransferase were 
enriched through this procedure. A large amount of ß-hexosaminidase activity was observed 
in the unbound fraction (Supernatant). This could be the portion of the enzyme released from 
lysosomes during the disruption by sonication. The purification was also confirmed by the 
separation of samples in two-dimensional electrophoresis (Fig. 4.4). 
Fig. 4.3: Two-dimensional separation of the pellet containing mitochondrial
proteins. The proteins  (20 µg) pelleted by centrifugation before immuno-affinity
purification. The sample was solubilised in 100 µl lysis buffer containing urea and
CHAPS. After isoelectric focusing for 20 h, proteins were separated on a 15 %
SDS-PAGE and stained with silver nitrate. 
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Table. 4.2: Purification of lysosomal membrane proteins by immuno-adsorption 
Material Protein 
(mg/ml) 
ß-glucosidase 
(mU/mg) 
ß-hexosaminidase 
     (mU/mg) 
Purification
factor 
Dense pool 1.53+/-0.28 15.3+/-2.4 1361+/-26.5     1 
Pellet 0.9+/-0.23 4.4+/-0.7 211+/-15.5   0.29 
Supernatant 1.27+/-0.17 7.87+/-0.85 7480+/-271   0.51 
Affinity purified 
vesicles 
0.93+/-0.35 48.4+/-10.3 1536+/-49.5    3.2 
 
As shown in the table, affinity purification resulted in a 3.2 fold enrichment of 
lysosomal ß-glucosidase activity (average of 3 independent experiments.) 
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Fig. 4.4: Two-dimensional separation of the lysosomal membrane proteins
after immuno-affinity purification. The lysosomal proteins (20 µg) purified by
immuno-affinity adsorption were solubilised in lysis buffer containing urea and
CHAPS. After isoelectric focusing for 20 h, second dimensional separation was
carried out on a 15 % acrylamide gel and stained with silver nitrate. 
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The affinity purification resulted in a significant purification of lysosomal vesicles as 
shown by enrichment of ß-glucosidase activity. The signals for the integral membrane 
proteins LAMP, LIMP, TPP-1, vacuolar ATPase subunits and ß-glucosidase were enriched as 
observed from the 2D analysis (Fig. 4.4) in comparison to the signals from whole dense pool 
(Fig. 4.1). 
 
Though the purification by immuno-affinity adsorption was quite successful and 
resulted in considerable enrichment of lysosomal proteins, the samples became contaminated 
with the antibody that was released from the beads. Another limitation of this procedure was 
regarding the recovery of the bound proteins from the beads in a native form. Detergents such 
as NP-40 and CHAPS were efficient for the extraction procedure. However, the antibodies 
from the beads contaminated the extracts. When the proteins were extracted with 
glycine/NaOH at pH 9, the antibody was not released but the efficacy of the subsequent 
binding was reduced to only 30-40 %, of the first time. On the preparative level this caused a 
limitation since a large-scale preparation could not be performed with the available antibody 
stock. 
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4.1.3  Purification of lysosomes by MME treatment 
A selective substrate-induced disruption of lysosomes was achieved (see 3.2.1.5) in a buffer 
containing methionine methyl ester (MME). This amino acid ester was taken up by the 
lysosomes, and degraded by the hydrolases contained within. Accumulation of methionine 
and methanol produced by the hydrolysis were likely to cause an osmotic imbalance and 
bursting out of the vesicles. The sub-lysosomal vesicles thus obtained were separated by 
centrifuging in a linear sucrose gradient. As a result, the lysosomal marker enzymes 
fractionated in fractions of lower density compared with mitochondria. 
 
An alternative method was sought to improve the removal of the contaminating 
vesicles. After the treatment of the lysosomes with MME, the incubation was continued in the 
presence of 10 mM MgCl2 at pH of 7.4. An aggregation of membranous materials was 
observed that could be removed by a low-speed centrifugation (5 min at 11,000 rpm). The 
aggregates contained a portion of the mitochondrial marker enzyme, succinate dehydrogenase 
depending on the concentration of MgCl2 used (Fig. 4.5). It was found that, to selectively 
sediment the mitochondrial contaminants, 10 mM MgCl2 was the optimal concentration. The 
major portion of the lysosomal proteins (ß-glucosidase) remained in the solution. 
 
 
 
 
 
 
 
 
 
  
Effect of MgCl2 concentration on Succ. Dhase 
sedimentation 
0
 
 
 
 
 
The proteins sedimented by centrifugation were analysed by 2D electrophoresis using 
thiourea/ASB-14 solubilisation system (Fig. 4.6) and was found to contain a high-intensity 
signal corresponding to the mitochondrial ATP synthase which was almost invisible in the 
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Fig. 4.5: The effect of MgCl2 concentration on the sedimentation
of succinate dehydrogenase. Samples disrupted with MME and
incubated without MgCl2, but centrifuged at 11,000 rpm were used as
controls and the activities measured from this sample without
centrifugation were taken as 100 %.
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supernatant. There were also weak signals for LAMP-2, LIMP-2 and TPP-1, but were weakly 
stained as compared with the one in the supernatant fraction. 
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 Fig. 4.6: The two-dimensional electrophoresis of the aggregated proteins
after the MgCl2 treatment. The aggregated proteins (20 µg) obtained by
MgCl2 treatment was solubilised in lysis buffer containing thiourea and ASB-14.
After isoelectric focusing for 14 h at 37°C, proteins were separated on a 15 %
acrylamide gel and stained with silver nitrate. 
 
 
 
 
Table. 4.3: Disruption of lysosomes with MME and removal of contaminants by 
incubation with 10 mM MgCl2 for 12 h, followed by centrifugation at 11,000 for 5 min. 
 Material ß-glucosidase 
(mU/mg) 
ß-hexosaminidase 
  (mU/mg) 
Succinate 
dehydrogenase(mU/mg)
Dense pool (DP) 42+/-12.3 845+/-35 6.3+/-1.8 
Lysate of DP by MME 63+/-9.5 412+/-16 6.48+/-1.67 
Supernatant fraction after 
MME-induced lysis of 
DP lysate and MgCl2 
incubation 
 
124+/-16.2 
 
950+/-28 
 
1.6+/-0.45 
Aggregate after the 
MgCl2 treatment 
21+/-4.2 75+/-7.4 8.27+/-0.44 
Lysosomal matrix 
fraction 
Not detectable 1732+/-45.2 Not detectable 
Lysosomal membrane 
fraction 
241+/-47.8 Not detectable Not detectable 
(Values given are the averages of 3 independent experiments) 
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The supernatant and pellet obtained after the MgCl2-induced aggregation was analysed 
on a Western blot after separation on a 10 % SDS-PAGE (Fig. 4.7). A polyclonal antibody 
against the subunit `a` of the vacuolar ATPase complex was used for the detection.  
 
EXT SUP PMMEkDa Fig. 4.7: Effect of MgCl2-
induced sedimentation on
vacuolar ATPase. The MME-
lysed lysosomes (MME), pellet
obtained after MgCl2 treatment
(P), supernatant after MgCl2
treatment (SUP) and the
membrane extracted with 1 %
(w/v) Triton X-100 (EXT), each 5
µg were solubilised in SDS-buffer
by incubating at 37 °C and
separated on a 10 % acrylamide
gel. After blotting to a PVDF
membrane, antibody against the
subunit `a` of V-ATPase was
used for the detection. Binding of
peroxidase conjugated secondary
antibody was visualised by the
ECL method. 
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All examined samples contained the equal amount (5 µg) of protein. In comparison to 
the starting material (MME), the signal for vacuolar ATPase subunit `a` was more prominent 
in the supernatant fraction obtained after cleaning with MgCl2 (SUP). In the pellet fraction-
where mostly contaminating proteins were observed, the signal was week. This suggests that a 
good degree of purification can be achieved by the MgCl2 treatment. When the supernatant 
was sedimented by ultracentrifugation and the sediment extracted with a detergent (1 % 
Triton X-100), a strong antibody signal was found in the soluble fraction.  
 
In addition to the signal corresponding to the nominal molecular mass (116 kDa), 
there was an additional signal around 200 kDa. Before the detergent extraction, this signal 
was weak. Its origin is not clear. One possibility would be a protein precipitation and 
aggregation preventing it from the downward movement along the gel. 
 
The supernatant obtained after MgCl2 treatment was analysed by two-dimensional 
electrophoresis. A specific enrichment of lysosomal marker proteins including LIMP-2, ß-
glucosidase, TPP-1 and the subunits from V-ATPase were observed in these cleaner 
membranes upon visualisation by silver staining (Fig. 4.8). 
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Ultracentrifugation of these vesicles provided lysosomal membranes (Fig. 4.9) with a 
high purity as shown by enrichment of membrane bound ß-glucosidase activity up to 6 fold 
(Table. 4.3). Activity of mitochondrial markers were too less to be calculated, which again 
suggested a good degree of lysosomal membrane enrichment. 
Fig. 4.8: Two-dimensional separation of lysosomal vesicles in the
supernatant after MgCl2-induced aggregation. The supernatant (20 µg)
obtained after MgCl2 treatment was solubilised with lysis buffer containing
thiourea and ASB-14. Sample was subjected to isoelectric focusing for 20 h at 37
°C and separated on a 15 % acrylamide gel. The polypeptides were visualised by
silver staining. 
 
The number and complexity of protein spots observed in the cleaned membranes after 
the removal of aggregates was decreased as compared to the preparations made by other 
procedures. A spot resembling the NPC-1 protein was visible upon silver staining as a faint 
band on a high molecular weight region of the gel. The appearance of this hydrophobic 
protein with 13 tentative transmembrane segments in the membrane preparations not only 
indicated a good quality of the membranes, but also an effective solubilisation in the 
thiourea/ASB-14 system as compared to the urea/CHAPS system. 
 
 
 
 
 
 
 
 49
CHAPTER 4. RESULTS 
 50
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Fig. 4.10: Two-dimensional electrophoresis of the lysosomal matrix
protein fraction. The matrix proteins (20 µg) in the supernatant fraction of
the lysosomal vesicles made by MME-treatment and MgCl2-induced
cleaning. The sample was solubilised in 100 µl lysis buffer containing
thiourea and ASB-14 and subjected to isoelectric focusing for 20 h at 37 °C.
Proteins were separated on a 15 % acrylamide gel, and stained with silver
nitrate. 
TPP-1 
200 
116 
98 
66 
45 
31 
21 
kDa pH 4 7 
Fig. 4.9: Two-dimensional separation of the lysosomal membranes
obtained after the removal of MgCl2-induced aggregates and the matrix
proteins. The membrane preparation (20 µg) obtained by the ultracentrifugation
of supernatant fraction after removal of aggregates was solubilised in 100 µl
lysis buffer containing thiourea and ASB-14 and subjected to isoelectric
focusing for 20 h at 37 °C. Proteins were separated in the second dimension on
a 15 % acrylamide gel, and stained with silver nitrate. 
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The supernatant obtained after the ultracentrifugation step contains the matrix proteins 
from the lysosomal compartment with an enrichment of up to 2 fold as shown by ß-
hexosaminidase activity measurement. Proteins in this fraction were separated by two-
dimensional electrophoresis and visualised by silver staining (Fig. 4.10). The sample was 
found to contain several glycosylated proteins. A major observation was the relative 
abundance of tripeptidyl peptidase-1 (TPP-1) in the matrix fraction. In comparison with the 
membrane fraction, the intensity of the spot in the matrix fraction was decreased. This 
suggested that during the separation of matrix proteins by the ultracentrifugation a larger 
portion of TPP-1 was sedimented with the membrane components. 
 
The pellet and supernatant obtained after MgCl2 treatment were analysed on separate 
sucrose density gradients, and activities were followed. Upon centrifugation in a self-forming 
sucrose density gradient, almost all the proteins from the supernatant (Fig. 4.11) were 
localised in the low-density zone of the gradient, whereas the proteins from the pellet sample 
were observed on a more dense area of the gradient (Fig. 4.12).  
 
Such an observation suggested that the pellet obtained after MgCl2 treatment was 
predominantly contaminating proteins. A small portion of the proteins- but distinct in its 
pattern from the general profile was found in the low-density area of the gradient. The protein 
pattern was similar to the supernatant obtained after MgCl2 treatment. This could be the 
portion of lysosomal vesicles that was trapped within the aggregates, and set freed by the 
dilution during the density gradient centrifugation. 
 
In the sucrose gradient, where the supernatant fraction obtained after the MgCl2-
induced was separated, most of the proteins were belonging to the lysosomes, and a very 
small portion of the total protein was found in the higher-density zone of the gradient. The 
observation was similar in the sucrose gradient where the aggregates were separated, but most 
proteins were located on the area where mitochondrial proteins would be expected in such a 
gradient.  
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Top Bottom
Fig. 4.11: The separation of membranes that were not aggregated in the
presence of MgCl2. The lysate after MME treatment (T) was separated by
centrifugation into supernatant (S) and pellet (P) fractions after MgCl2 treatment.
The supernatant fraction was separated by centrifuging at 100,000 × gmax for 10 h
on a linear gradient of sucrose (30 %-55 % sucrose) and collected into 14 fractions
of equal volumes. From each fraction, 0.5 µg protein was incubated with SDS
solubiliser, separated on a 15 % SDS-PAGE and stained with silver nitrate. 
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Fig. 4.12: The separation of membranes aggregated in the presence of MgCl2.
The lysate after MME treatment (T) was separated by centrifugation into supernatant
(S) and pellet (P) fractions after MgCl2 treatment. The pelleted fraction was separated
by centrifuging at 100,000 × gmax for 10 h on a linear gradient of sucrose (30 %-55 %
sucrose) and divided into 14 fractions of equal volumes. From each fraction, 0.5 µg
protein was incubated with SDS solubiliser, separated on a 15 % SDS-PAGE and
stained with silver nitrate. 
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4.2   Analysis of detergent resistant microdomains on the lysosomal membrane  
 
4.2.1 Flotation experiments of detergent resistant microdomains  
 The presence of detergent resistant micodomains (DRM) on the lysosomal membrane has 
been reported (Taute et al., 2002). These micro domains were found to be enriched in the 
lysosomal membrane acetyl-CoA: alpha-glucosaminide N-acetyl transferase (AcTf) activity. 
A proteomic approach was carried out for the identification of proteins associated with a 
DRM fraction from lysosomal membrane. This was done by extracting the whole proteins 
from the lysosomal membrane under specific conditions of detergent concentration  (1  % 
Triton X-100) and temperature (4 °C). The extract was mixed with iodixanol to obtain a 
concentration of 40  % followed by layering it on the bottom of the gradient. After an 
ultracentrifugation for 5h the floating low-density material was collected. 
 
All the fractions obtained from the gradient were analysed by separating on an SDS-
PAGE and visualising by silver staining (Fig. 4.16). There were a number of proteins that 
showed a uniform distribution throughout the gradient. On the other hand, a specific 
enrichment of a small population of polypeptides was observed in the fractions containing the 
DRMs. Most of them were distinct from the majority of proteins. A few proteins were present 
only in the upper fractions while a few others, though present in all fractions most abundantly 
visible in the low-density fractions.  
 
The lysosomal preparations showed PLAP activity. This GPI-anchored protein is 
localised mainly in the plasma membrane and associated with DRMs (Snyers et al., 1999). It 
provided an internal control for the flotation experiments. Initial experiments were performed 
using UC membranes of less purity, which showed an enrichment of AcTf and PLAP (Fig. 
4.13) in the floating fractions though the recovery of AcTf was only around 10  %. 
 
As described by others, the floating properties of these enzymes were highly 
dependent on the temperature of extraction. When the extraction was carried out at a higher 
temperature (37 °C) the floatation was no longer observed (Fig. 4.14). The DRMs are known 
to disintegrate in the detergent solutions at higher temperatures. 
 
The recoveries of both PLAP and AcTf were very low when the extraction was done 
at 37 °C (Fig. 4.14). Similar results were obtained when the extraction was carried out at 4 °C 
after a pre-incubation with 20 mM of the cholesterol-depleting agent, methyl-ß-cyclodextrin 
(MBCD). Cholesterol is an important component of the DRMs. Its selective depletion resulted 
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in a decrease in activity of the proteins associated with the DRMs and the floatation was no 
longer observed. 
 Floatation of DRM- associated proteins on Optiprep gradient
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Fig. 4.13: The distribution of AcTf and PLAP on iodixanol gradient.
The membranes were extracted at 4 °C, and separated on a step-gradient
of iodixanol. (Activities expressed as percentage of recovered) 
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Fig. 4.14: The Distribution of AcTf and PLAP when extracted at 37 °C. 
(Activities expressed as percentage of recovered) 
 
 
 
 
 
 
 
 
 
 
 
 
The detergent used for extraction was critical in obtaining the DRMs. Experiments 
carried out with CHAPS, NP-40, octyl thioglucoside and Lubrol did not show any specific 
floating of either PLAP or AcTf irrespective of the temperature of extraction (data not 
shown). All experiments in the preparative level were thus performed with Triton X-100 and 
the extraction was performed at 4 °C. 
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A significant portion of the lysosomal V-ATPase was found in the low buoyant 
density fractions 2 and 3 (Fig. 4.15). It has been reported recently that the DRMs isolated 
from plasma membranes contain several subunits of V-ATPase (Galli et al., 1996, Blonder et 
al., 2004, Yoshinaka et al., 2004) and that in yeast such an assembly of vacoular ATPase is 
necessary for the surface delivery (Bagnat et al., 2000). However, the recovery of V-ATPase 
activity after the iodixanol gradient was very low. It is not clear if the activity of the V-
ATPase was decreased as a whole or due to a selective detachment of one or more subunits 
diminished the activity. 
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Fig. 4.15: The distribution of V-ATPase activity in fractions of
OptiprepTM density gradient. The membranes were extracted at 4 °C
with 1 % (w/v) Triton X-100 and separated on a step-gradient of
Iodixanol (Activities expressed as percentage of recovered) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.2   Identification of floating components of the lysosomal membrane 
To identify proteins that are associated with the lysosomal DRMs, mass spectrometric 
analysis was carried out after pooling fractions from 3 separate OptiprepTM density gradients. 
The lysosomal membranes that were disrupted by treatment with MME, and cleaned by 
MgCl2 were used for the analyses. Separation of proteins was done on a 15  % SDS-PAGE 
(Fig. 4.16) for analytical level and stained with colloidal Coomassie blue (Fig. 4.17) for the 
mass spectrometric analysis as mentioned (see 3.2.1.10.5). An aliquot of the sample was run 
simultaneously for silver staining as a control. Protein bands were cut out from the Coomassie 
blue-stained gel, and tryptic digests were used for Maldi-TOF and corresponding proteins 
were identified (Table. 4.4). 
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Out of the 9 protein bands analysed, 5 subunits of V-ATPase were identified to be present in 
the DRM fractions. These observations are correlating to the findings obtained. Placental 
alkaline phosphatase was a major protein identified in the band numbered 3 with the highest 
mowse score of 180. Though the floating fractions showed activity for AcTf, none of the 
bands identified gave corresponding results. This might be due to the very low content of this 
protein in the fractions analysed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                       Fractions 
    1   2   3    4    5   6   7    8   9  10  11  12 13 14 
TOP Bottom 
ExtMME
9 
8
7
5
6
4
3
2
1
kDa
Fig. 4.16: OptiprepTM gradient fractions prepared from the MME lysed lysosomal 
membranes. Lysosomes after MME-mediated lysis (MME), and extraction with Triton 
X-100 at 4 °C (Ext) were separated on an optiprepTM gradient into 14 fractions. From 
each sample, an aliquot containing 0,5 µg protein were solubilised and separated on 
a 15 % SDS-PAGE, for staining with silver nitrate.  
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Fig. 4.17: OptiprepTM gradient
fractions prepared from MME
lysed lysosomal membranes for
mass spectrometric analysis.
For the identification of proteins
associated with DRMs, low-
density fractions (fractions 1and 2)
from  three different gradients
were pooled, concentrated (DRM)
by precipitating with 4 volumes of
cold acetone and separated on a
15  % SDS-PAGE after
solubilisation. The separated
protein was stained by colloidal
Coomasssie blue and the protein
bands were analysed by Maldi-
TOF after digesting with trypsin. 
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  Table. 4.4: Proteins identified by Mass spectrometry from lysosomal DRMs 
Spot 
number 
Protein 
identified 
Mowse 
score 
Modification Mass 
tolerance 
(Da) 
GRAVY    
score 
1 Vacuolar ATPase 
subunit a (V0a) 
83 Carbamidomethyl 0.1 0.009 
2 LIMP-2 64 Carbamidomethyl 0.1 -0.043 
3 Placental alkaline 
phosphatase 
(PLAP) 
180 Carbamidomethyl 0.1 -0.207 
4 Vacuolar ATPase 
subunit B (V1B) 
74 Carbamidomethyl 0.1 -0.174 
5 Vacuolar ATPase 
subunit D (V1D) 
120 Carbamidomethyl
Oxidation (M) 
0.2 -0.444 
6 Annexin I 75 Carbamidomethyl 0.2 -0.426 
7 Vacuolar ATPase 
subunit E (V1E) 
76 Carbamidomethyl
Oxidation (M) 
0.2 -0.532 
8 Neural adhesion 
molecule NB-3 
(fragment) 
66 Carbamidomethyl 0.25 -0.255 
9 No match 
(V-ATPase-V0c 5 
peptides found) 
Not 
significant 
Carbamidomethyl
Oxidation (M) 
0.5 1.04 
 
Identification of lysosomal membrane vacuolar ATPase subunits as components of the 
DRMs was of relevance as the same observations have been published by others, but from 
other organelles and tissue types. Isolation and functional reconstitution of this proton pump 
could provide a system to understand the role of these lipid domains on the enzymes` stability 
and biological activity as well as to study the inhibitory effects of a few chemically derived 
agents, which are relevant to the pathology of lysosomes. 
 
4.3  Isolation of vacuolar ATPase 
 
4.3.1    Affinity purification of V-ATPase 
For the isolation of the vacuolar ATPase, biochemical techniques utilising its affinity to ATP 
were checked. The (AB)3 cluster in the V1 domain is responsible for ATP cleavage. For 
isolating the protein complex, immobilised ATP, coupled to Sepharose was used as a ligand. 
The ATP in the resin was coupled through its γ-phosphate group so that there cannot be any 
cleavage of the substrate upon protein binding (manufacturer's instructions). Though there 
was a clear binding of ATP-binding proteins (Fig. 4.18), it was found that the resin bound 
proteins including the contaminating ATPase of mitochondrial origin. The elution procedure 
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with a higher concentration of ATP (20mM) interfered with the enzyme activity 
measurements, based on Pi generation using 200 µM ATP as the substrate even after dialysis. 
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Fig. 4.18: Purification of ATP-binding proteins by affinity chromatography.
The lysosomal membranes prepared by MME-induced lysis and ultracentrifugation
was extracted with 1 % (w/v) Triton X-100 (Ext). This was incubated with the ATP-
acrylamide resin and unbound proteins (UB) removed by centrifugation followed by
a step-wise elution of bound proteins using NADH, ADP and ATP. Aliquots
containing 0.5 µg protein from each fraction were incubated with solubiliser,
separated on a 15 % SDS-PAGE, and visualised by silver staining. 
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4.3.2  Isolation of V-ATPase by gel filtration 
The V-ATPase is a high molecular weight protein complex, which made its separation 
possible by gel filtration. The gel filtration was performed using the lysosomal membranes 
prepared by MME-induced disruption of dense pool and removal of contaminating proteins 
through a cleaning step by incubation with MgCl2 and removal of the aggregates by 
centrifugation. The proteins were extracted with 1 % Triton X-100 and 0.25 % CHAPS (see 
3.2.1.6) in presence of 20 mM methyl ß-cyclodextrin, to disrupt the lipid mediated assembly 
of proteins in the DRMs. The extraction was done at room temperature for 30 min. Fractions 
from the gel filtration were collected and various enzymes were assayed. Multiple ATPase 
activity peaks were observed in the fractions (Fig. 4.19). Only the activity near the void 
volume was sensitive to N-ethylmaleimide (NEM). These fractions (Fractions 9-12) from the 
gel filtration corresponded to 950-1000 kDa. They were pooled and used for further analysis.  
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 Fig. 4.19: ATPase activity from the fractions of gel filtration. The lysosomal membranes
were prepared from dense pool by the MME-induced disruption followed by MgCl2 mediated
aggregation of mitochondrial contamination and its removal by centrifugation. The membranes
(150-200 µg) obtained were extracted with 1 % Triton X-100 and 0.25 % CHAPS in presence
of 20 mM methyl-ß-cyclodextrin at room temperature so as to get a protein concentration of 75-
100 µg/ml. The extract was separated by gel filtration using a Superdex-100 column. Fractions
were collected and ATPase activity was measured in the presence and absense of NEM. (One
unit of ATPase activity is defined as the amount of inorganic phosphate in micromoles
generated by the enzyme during one hour of incubation with the substrate-ATP.) 
 
 
 
 
 
The later fractions (13-16) were enriched in the activity of AcTf. This suggests either 
the complex molecular structure of the protein or the possibility of a supra-molecular 
assembly the protein is involved in, which was not disrupted by the treatment with 
MBCD.The activity of PLAP was also found in the fractions of V-ATPase activity. To 
confirm that the ATPase activity from these fractions was attributed to V-ATPase, the 
ATPase activity fractions were assayed in the presence of L-Phenylalanine, an inhibitor of 
PLAP (Fishman, 1987). L-Phenylalanine in millimolar concentrations affected the activity of 
PLAP, while concentrations up to 50 mM did not influence the activity of V-ATPase at all 
(Fig. 4.20). 
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Inhibition of PLAP by L-Phenylalanine
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Fig. 4.20: Effect of L-Phenylalanine on PLAP and V-ATPase activities. L-phenylalanine 
at 50 mM concentration completely inhibits PLAP, but had little effect on V-ATPase activity.
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The fractions showed V-ATPase activity obtained from the gel filtration were analysed on 
SDS-PAGE (Fig. 4.21). 
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 Fig. 4.21: Characterisation of proteins in the fractions of gel filtration. 
The lysosomal vesicles prepared by MME-induced lysis of dense pool were
incubated with MgCl2. After removing the aggregated proteins by centrifugation,
lysosomal membranes were prepared by ultracentrifugation and extracted at
room temperature (Ext) with 1 %Triton X-100 and 0.5 % CHAPS in presence of
20 mM methyl-ß-cyclodextrin.The extract was separated by gel filtration and
the fractions were solubilised in SDS solubiliser for separating on a 15 % SDS-
PAGE. The proteins were visualised by silver staining.
 
 
  
 
 
The ATPase activity fractions were separated  on two-dimensional electrophoresis 
(Fig. 4.22) using thiourea/ASB-14 solubilisation system after concentrating the samples by 
precipitating with cold acetone. A protein spot corresponding to the accessory subunit of V-
ATPase (Ac 45) was found to be enriched in the fractions analyesd. Since several of the V-
ATPase subunits have a basic isoelectric point (Table. 1.2), they could not be detected in the 
regular two-dimensional systems. Furthermore, the resolution of protein spots were not 
satisfactory, possibly due to the more hydrophobic proteins present in these samples or the 
lipids that are part of this complex. 
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 Fig. 4.22: Two-dimensional separation of the V-ATPase activity fractions 
prepared by gel filtration. The fractions of gel filtration (9-12) were solubilised in 
lysis buffer containing thiourea and ASB-14 and subjected to isoelectric focusing 
for 20 h. Proteins were separated on a 15 % SDS-PAGE in the second dimension 
and visualised by silver staining. The arrowheads indicate a series of protein 
spots resembling an ATPase accessory protein (Ac45) that has been identified in 
a separate experiment in our group (Bernd Schroeder, personal communication) 
 
 
 
 
As an alternative method for the separation of vacuolar ATPase polypeptides, a 
diagonal electrophoresis was performed with the cationic detergent CETAB for the first 
dimensional separation followed by second dimensional SDS-PAGE (see 3.2.1.12). This was 
efficient in resolving the hydrophobic proteins and the basic polypeptides of V-ATPase 
complex. 
 
For a comparison of the protein profile, the lysosomal membrane extracts used for gel 
filtration was also subjected to CETAB-PAGE. On staining with silver nitrate, this sample 
showed complicated pattern with several protein signals (Fig. 4.23). The fractions of gel 
filtration containing the NEM-sensitive ATPase activity were pooled, concentrated by 
precipitating with 4 volumes of ice-cold acetone and separated on a CETAB-PAGE. On silver 
staining, these fractions showed characteristic protein pattern with less complexity (Fig. 4.24), 
suggesting a high degree of purification with respect to V-ATPase. The majority of proteins, 
which were clearly visible in the starting material, were removed by the gel filtration. 
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 Fig. 4.23: Two-dimensional separation of detergent-extracted lysosomal
membrane, separated on CETAB/ SDS-PAGE. The purified lysosomal membranes
were extracted with 1 % Triton X-100 and 0.25  % CHAPS for gel filtration and an
aliquot of 10 µg protein was separated on a 8 % CETAB gel. After equilibration, the
proteins were separated on a 15 % SDS-PAGE and visualised by silver staining. 
 
 
 
Fig. 4.24: Two-dimensional separation of the V-ATPase activity fractions from gel
filtration separated on a CETAB/SDS-PAGE. The MME- treated lysosomal membranes
were extracted with detergents and separated by gel filtration. NEM-sensitive ATPase
activity fractions were separated on a 8 % CETAB gel. After equilibration, the proteins
were separated on a 15 % acrylamide gel and stained with silver nitrate. 
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To identify the proteins present in these fractions, a preparative two-dimensional 
electrophoresis (CETAB/SDS) was performed with 100-µg of the sample, and stained with 
colloidal Coomassie blue (Fig. 4.25). The protein spots were excised, digested with trypsin, 
and mass spectrometric analysis was carried out. 
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Fig. 4.25: Two-dimensional separation of the V-ATPase activity fractions separated by 
CETAB/SDS-PAGE and analysed by mass spectrometry. The lysosomal membranes 
purified by MME treatment and incubation with MgCl2 were extracted with detergents and 
separated by gel filtration. NEM-sensitive ATPase activity fractions were separated on a 8 % 
CETAB gel. After equilibration, the proteins were separated on a 15 % acrylamide gel and 
stained with colloidal Coomassie blue.The spots were identified by Maldi-TOF. 
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The protein spots when analysed by mass spectrometry showed subunits of vacuolar 
ATPase, which were mostly from the V1 domain. There were several spots that could not be 
identified by Maldi-TOF. From the V0 domain, only one subunit-V0d was identified in the V-
ATPase activity fractions. The subunits that are part of the V0 domain are hydrophobic and 
yield only few peptides upon tryptic digestion. The signal corresponding to the accessory 
subunit of V-ATPase- Ac 45 was quite evident in the two-dimensional gels with 
thiourea/ASB-14 solubilisation system. This polypeptide was also not identified from the 
spots analysed by mass spectrometry. There were no other proteins with nucleotidase activity 
identified from this sample confirming that the ATPase activity found was entirely due to the 
V-ATPase. 
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4.4   Reconstitution of vacuolar ATPase 
The V-ATPase activity fractions prepared through gel filtration was reconstituted into uni-
lamellar liposomes in presence of 0.5 % Triton X-100. The proteoliposomes obtained was 
suspended in the defined volume of reconstitution buffer. The reconstitution provided an 
opportunity to examine the effects of V-ATPase inhibitors in the presence of defined lipids. 
 
The reconstitution was performed using egg yolk lecithin (see 3.2.3) and the 
reconstituted proteins were suspended in reconstitution buffer. The ATPase activity was 
measured by estimating the liberation of inorganic phosphate by the colorimetric assay. As a 
control, proteoliposomes were incubated in the substrate buffer without ATP to assure that the 
inorganic phosphate measured was not endogenous, but resulted from ATP hydrolysis by the 
enzyme. It was found that inclusion of cholesterol in the liposomes resulted in a better 
recovery of most of the lysosomal membrane enzymes in the reconstituted fraction (Christian 
Wrocklage, personal communication). Taking this into account, the subsequent experiments 
for reconstituting the V-ATPase were performed with cholesterol contributing 22.5 % 
(mg/mg) of total lipid in the liposomes. 
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Fig. 4.26: The reconstitution of vacuolar ATPase. Reconstitution 
of V-ATPase into liposomes was done in presence and absence of
cholesterol. The total activity from the extract (Start) is considered 
100 %. The non-incorporated (Sup), wash (Wash) and incorporated
V-ATPase activities (Pro. Lip.) are expressed as percentage of total. 
 
 
 
 
 
The amount of V-ATPase activity in the proteoliposomes was 14.5 % of the initial 
activity when the reconstitution was performed with unilamellar vesicles made of solely 
lecithin. The incorporation of cholesterol into the vesicles increased the reconstitution 
efficiency by a factor of 2 (Fig. 4.26). A corresponding decrease in ATPase activity in the 
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non-incorporated fraction was also observed in reconstitutions done in the presence of 
cholesterol while there was no significant difference between the aliquots of washes. 
 
The protein pattern of the reconstituted vesicles was analysed on diagonal 
electrophoresis. The solubilised V-ATPase used for the reconstitution (Fig. 4.27) was 
analysed as a control for comparison. The major protein spots ranged from 20 to 100 kDa. 
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Fig. 4.27: Two-dimensional separation of the V-ATPase used for reconstitution
on a CETAB/SDS-PAGE. The solubilised material (5 µg) used for reconstitution was
separated on a 8 % CETAB gel. After the equlibration the proteins were separated on
a 15  % SDS-PAGE and visualised by staining with silver nitrate. 
 
 
 
After reconstitution and removal of the detergent, the aggregated material was 
sedimented by centrifuging the sample at 14,000 rpm for 15 min. The aggregation is possibly 
due to a denaturation of a small portion of proteins during the procedure of reconstitution. The 
pellet obtained containing the aggregated proteins was analysed on a CETAB/SDS-PAGE and 
visualised by staining with silver nitrate (Fig. 4.28). The protein pattern resembled to the 
staring material (V-ATPase activity fraction from gel filtration) in that the prominent spots 
were the same.  
 
The reconstituted proteins were separated from the remainder by sedimenting the 
liposomes by ultracentrifugation. The supernatant containing the non-incorporated proteins 
was analysed by diagonal electrophoresis. This fraction was enriched in proteins that were 
predominantly of low molecular weight (Fig. 4.29). 
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Fig. 4.28: Two-dimensional separation of the proteins that were aggregated during
the reconstitution on a CETAB/SDS-PAGE. The non-incorporated and aggregated
proteins (5 µg) were removed by centrifugation. The aggregated protein sample was
separated on an 8 % CETAB-PAGE followed by a 15 % SDS-PAGE and stained with silver
nitrate.
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Fig. 4.29: Two-dimensional separation of the non-reconstituted proteins 
separated by centrifugation on a CETAB/SDS-PAGE. The proteins that were 
not reconstituted were separated as the supernatant fraction by ultra 
centrifugation. An aliquot containing 5 µg proteins was solubilised and separated 
on an 8 % CETAB gel. After the equilibration step, the proteins were separated 
on a 15  % SDS-PAGE followed by visualising the polypeptides by silver staining.
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Fig. 4.30: Two-dimensional separation of the proteoliposomes containing the
reconstituted V-ATPase on CETAB/SDS-PAGE. The proteoliposomes obtained by
ultra centrifugation containing the reconstituted V-ATPase (5 µg) was separated on an
8 % CETAB gel. After the equlibration, the proteins were separated on a 15 % SDS-
PAGE and stained with silver nitrate. 
kDa 
The proteoliposomes obtained after ultra centrifugation were resuspended in the 
reconstitution buffer and the protein pattern analysed on a CETAB-PAGE (Fig. 4.30). The 
protein pattern showed most of the major spots that were present in the starting material. 
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The orientation of reconstituted vacuolar ATPase was analysed by examining the 
accessibility of V1 domain components to the substrate-ATP. The ATPase activity from the 
proteoliposomes was measured in the presence and absence of 0.5 % Triton X-100 at a final 
concentration. As controls, fractions from the starting material, washes and the non-
incorporated material were analysed too for the comparison (Fig. 4.31). 
 
The ATP cleaving domain of the vacuolar ATPase is oriented on the cytosolic side of 
the lysosomes. If the reconstitution resulted in the correct orientation of the complex, the V1 
domain of the ATPase complex should have an access to ATP in the medium. If there were 
populations of proteoliposomes with the protein in both orientations, only partial ATP 
cleavage would occur depending on the percentage of properly oriented enzyme. After the 
detergent treatment, the vesicles were disrupted providing both orientations an access to ATP. 
There was no major increase in the activity due to the detergent. This suggested that after the 
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reconstitution, the V1 portion was present at the outer surface of the liposomes as it would, in 
the case of the protein complex in the lysosomal membrane. 
 The effect of detergent on reconstituted v-ATPase 
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 Fig. 4.31: The Effect of detergent on reconstituted V-ATPase activity.
Samples including the starting material (Start), non-incorporated portion
(Sup), wash (wash) and proteoliposomes (Pro. Lip) were assayed for ATPase
activity in presence and absence of 0.5 % Triton X-100. Activity of the
samples in the absence of Triton X-100 is expressed as 100 % in each case. 
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4.5   Inhibitory studies on reconstituted V-ATPase 
After reconstitution, the V-ATPase was subjected to inhibitory studies to check the effects of 
several chemical agents. The isolated enzyme was found to be sensitive to N-ethylmaleimide 
(NEM) and bafilomycin-A1 in a dose-dependant manner, both of which are reported 
inhibitors of vacuolar type ATPases along with a lipofuscin derivative designated as A2-E. 
 
N-ethylmaleimide, the sulphhydryl modifying agent is a well-known inhibitor of 
vacuolar type ATPases. To analyse the inhibitory effects of NEM, different concentrations 
were used. Reconstituted vacuolar ATPase was diluted with water and incubated with NEM 
upto 2 mM concentration at room temperature (25 °C) for a period of 15 min. After this time, 
the solution containing the substrate was added. The extent of ATP hydrolysis by the enzyme 
within a period of 3 h was measured. The activity obtained with the non-treated 
proteoliposomes was considered to be 100 % (no inhibition). 
 
V-ATPase  inhibition by NEM
0
20
40
60
80
100
0 0,25 0,5 0,75 1 1,25 1,5 1,75 2 2,25
NEM  (m M )
In
hi
bi
tio
n 
(%
)
 
 
 
 
 
 
 
 
 
 
Fig. 4.32: The effect of NEM on the reconstituted lysosomal ATPase.
An aliquot (5 µl) of the reconstituted V-ATPase corresponding to 50-55
units of enzyme activity were used in every trial. The activity from the
untreated sample was considered to be 100 % (no inhibition) and activities
obtained after the pre-treatment with different NEM concentrations are
expressed (average of 2 independent experiments) as the net activity. 
 
 
 
 
 
Inhibition of v type ATPase by NEM has been reported to be complete when used at a 
concentration of 1 mM (Arai et al., 1993). However, in our experiments with reconstituted 
lysosomal ATPase, only 80 % inhibition was observed at the same concentration. When a 
concentration of 2 mM NEM was used for inhibition, 95 % of the ATPase was inhibited  
(Fig. 4.32). 
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Another inhibitor used was bafilomycin-A1, which is reported to inhibit the vacuolar 
ATPase at a concentration of 100 nM completely. In the experiment shown in Fig. 4.33, at an 
inhibitor concentration of 1 nM, > 30 % inhibition was observed. At 100 nM concentrations, 
the inhibition was more than 90 %. 
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Fig. 4.33: Inhibition of V-ATPase by bafilomycin A-1after reconstitution.  
To a 5 µl aliquot of reconstituted V-ATPase corresponding to 50-55 units of
the enzyme activity, different concentrations of bafilomycin A-1 were added.
The activity obtained from the untreated sample was considered to be 100 %
(no inhibition), for comparing the concentration-dependence of inhibition and
an average of two independent measurements are shown for each value. 
 
 
 
 
The effect of sodium azide, an inhibitor of F-type ATPases was also investigated on 
the proteoliposomes. There was no significant inhibition observed with sodium azide when a 
maximum concentration of 10 µM was used (Data not shown).  
 
The inhibitory effect of synthetic A2-E was analysed on the isolated and reconstituted 
vacuolar ATPase. This lipofuscin derivative is a reported inhibitor of vacuolar proton pump in 
retinal pigment epithelial cells and contributes to the pathology of age-related macular 
degeneration and vision loss. A2-E is shown to affect both the ATP-hydrolysis and proton 
translocation in a dose-dependent manner in the intact organelles (Bergmann et al., 2004). 
These studies showed a dose-dependent inhibition of the ATPase activity by the A2-E  
(Fig. 4. 34). 
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V-ATPase inhibition by A2-E
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Fig. 4.34: Inhibition of reconstituted vacuolar ATPase by A2-E. Different
concentrations of A2-E were added to 5 µl aliquots of the reconstituted
ATPase and ATPase activity was measured after the pre-treatment. The
activity obtained from untreated sample was considered to be 100 %. An
avera
 
 
 
ge of two independent experiments is given in the graph.
 
As a control, the purified lysosomal membranes were extracted with 0.5 % Triton X-
100 and reconstituted. The effect of A2-E on these vesicles was analysed for a comparison 
(Fig. 4.35). The extent of inhibition was considerably low when compared to the purified 
ATPase. This suggests that the amount of V-ATPase in the membranes is only a small 
percentage of the total ATPase activity. Such an observation is compatible with the partial 
sensitivity (Fig. 4.18) of the ATPase activity fractions in the low-molecular area of the gel 
filtration. 
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Fig. 4.35: Effect of A2-E on the purified lysosomal membrane
extract after reconstitution. Different concentrations of A2-E
were checked on the lysosomal membrane extracts after
reconstitution. Every trial of the experiment was performed with
50-55 units of ATPase activity. The activity obtained from
untreated sample was considered to be 100 %. 
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5     Discussion 
5.1  Purification of lysosomal membrane proteins 
 A biochemical study on the membrane protein complexes from the lysosomal compartment 
demanded a convenient and efficient strategy to prepare lysosomal membranes of good 
quality to work with. Though there were several attempts for the purification and a proteomic 
analysis of the lysosomal membrane proteins with medical relevance, they are far from 
complete (Journet and Ferro, 2004, Bagshaw et al., 2003). This is largely due to the low-
abundance and high hydrophobicity of the lysosomal membrane proteins in addition to the 
contamination of lysosomal preparations with non-lysosomal proteins. In the current study, 
several biochemical techniques were employed for the purification and analysis of the 
lysosomal membrane proteins isolated from human placenta and the scheme adopted for the 
study is shown in the chart.  
 
 
 
 
 
Homogenate from human placenta  
(Percoll© density gradient centrifugation) 
 
 
 
 
 
Dense pool lysosomes 
(MME- induced lysis of lysosomal vesicles and  
aggregation of major contaminants by MgCl2) 
Purified lysosomal membrane 
SDS-PAGE
2D Electrophoresis (thiourea/ASB-14)
CETAB-PAGE
Isolation of V-ATPase Reconstitution
Inhibitory 
studies 
Mass Spectrometry
Maldi-TOF 
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Fig. 5.1: The isolation and characterisation of lysosomal membrane proteins 
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The isolation of lysosomes from placenta homogenates by Percoll© density gradient 
centrifugation resulted in a 50-55-fold enrichment as suggested by an increase in the specific 
activity of the membrane bound ß-glucosidase. This has been reported by Diettrich et al. 
(1996). Though the enrichment of lysosomes and separation of a major fraction of 
mitochondria was achieved by this procedure, the samples still contained non-lysosomal 
proteins, as is known from other reports as well (Chatway et al., 1998). There are reported 
improvements in the further purification by a second step of Percoll© gradient centrifugation 
(63+/-12 fold purification) from rat liver lysosomes (Symons and Jonas, 1987) but with low 
yields.  
 
As an alternative procedure, purification of lysosomal vesicles using immuno-affinity 
adsorption was employed. A monoclonal antibody recognising the lysosomal membrane 
protein, LAMP-2 coupled to C1Z-Eupergit beads was used for this purpose. This resulted in 
purification of lysosomal vesicles as shown by 3.2-fold enrichment in the membrane bound 
 ß-glucosidase activity. However, upon elution of the bound proteins from the beads, the 
detachment of antibody chains from the support contaminated the proteins. Moreover the 
detachment of antibody from the beads limited the re-use of the beads, demanding high 
amounts of antibody reserves for the complete analyses. 
 
Separation of vesicles based on polyethylene glycol phase-separation procedure was 
examined, but without much success. A substrate-induced lysis of the lysosomes by 
methionine methyl ester  (Goldman and Kaplan, 1973, Reeves, 1979) yielded vesicles that 
could be separated from the bulk of mitochondria.  The lysosomal vesicles thus obtained were 
of relatively low buoyant density as compared to the mitochondria and this made the 
enrichment of these vesicles possible using density gradient centrifugation in a linear sucrose 
gradient. A good degree of purification was observed and the lysosomal vesicles were 
collected from the low-density fraction of the gradient (fractions 3-5) whereas the 
mitochondrial proteins were present in higher density fractions (fractions 6-9). Though, this 
purification strategy resulted in a high degree of purification (6-8-fold enrichment of the 
membrane-associated ß-glucosidase activity, (Bernd Schroeder, personal communication) the 
procedure was time-consuming and laborious.  
 
An alternative strategy was explored to shorten this procedure. It has been reported 
that the divalent cation Mg2+ induced aggregation of the mitochondrial membranes (Stonet et 
al., 1978, Morris et al., 1979, Kwan, 1986). Therefore an incubation with MgCl2 was 
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performed after the disruption of the lysosomes by MME treatment. The aggregated 
membranes, mainly mitochondria were sedimented by centrifugation and this resulted in an 
additional 3-fold purification of lysosomal membranes in the supernatant fraction. The 
lysosomal membranes were then prepared by ultracentrifugation. The specific activity of the 
lysosomal membrane-bound ß-glucosidase (250-300 mu/mg) was increased several folds due 
to the separation of a large portion of the contaminants and of the matrix proteins. Taken 
together, there was a 6-fold purification of lysosomal membranes from the dense pool, 
yielding 300-fold purification from the placental homogenate level. A similar purification of 
the human placental lysosomal membranes has not been reported before. 
 
An improvement that was achieved by treating the MME-disrupted vesicles with 
MgCl2 appeared to be the removal of a major fraction of the mitochondrial contamination. 
Such a step allowed a convenient, rapid and efficient method of purifying the vesicles from 
disrupted lysosomes, and thus the membranes. On an average, the yield of protein obtained in 
the purified lysosomal membrane fraction was only 3.5-4 % of the amount of proteins that 
were present in the dense pool lysosomes. Nevertheless, 25-28 % of the activity of the 
lysosomal membrane associated ß-glucosidase activity was recovered after the final stage of 
purification. The efficiency of purification was confirmed by two-dimensional analyses of 
proteins from all the fractions, as well as by the activity measurements of marker enzymes of 
both lysosomal (the membrane-bound ß-glucosidase) and the mitochondrial (succinate 
dehydrogenase) compartments. In the two-dimensional analyses, the relative intensities of the 
mitochondrial protein spots were strongly reduced as compared to the marker proteins from 
the lysosomal membrane. 
 
An interesting observation during the isolation of lysosomal membranes using the 
current strategy was the co-sedimentation of a tentatively matrix protein (Golabek et al., 
2002) tripeptidyl peptidase-1 (CLN2) along with the membranes. The possibility of an ionic 
interaction involved in this was examined by washing the membranes with 0.5 M NaCl. The 
washing step resulted in the removal of only 30-35 % of the biologically active TPP-1. 
Another possibility would be the occurrence of multiple forms of the protein leading to 
different levels of interaction with the lysosomal membrane. To check this, the protein 
samples from the membrane and matrix fractions were resolved separately on two-
dimensional electrophoresis and checked for their detection by an antibody. The antibody 
recognised the protein from both fractions at the same area of molecular weight and 
isoelectric point, suggesting that the protein form present in the matrix is probably the same as 
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that co-sedimenting with the membranes. There are interactions among the different proteins 
of the CLN family, especially the lysosomal pH regulating protein battenin (CLN3) and a 
soluble lysosomal protein of unknown function that is defective in the late infantile variety of 
the CLN disease (CLN5) with TPP-1 which is also called CLN2 (Vesa et al., 2002), studied 
using co-immuno precipitation. This enlightens a possible protein-protein interaction 
responsible for keeping a fraction of the CLN2 in the lysosomal membrane, though attempts 
to cross-link in vitro with DSP (data not shown) were not successful. 
 
The lysosomal membrane carries a number of yet uncharacterised proteins performing 
important functions as evident from the diseases caused by mutations affecting these proteins. 
These include the Niemann-Pick C1 type protein involved in the cholesterol metabolism, the 
Sanfilippo type C protein required for the heparan sulphate degradation, sialic acid transpoter, 
cystine transporter, transport proteins for ions and small molecules etc. to name a few. 
Though many of them are characterised with respect to their gene loci, very little information 
is currently available regarding the protein as such. The lysosomal membranes prepared by 
MME and MgCl2 treatment can be proposed for the enrichment, isolation and characterisation 
of these proteins.  
 
5.2  Analysis of DRMs from the lysosomal membrane 
The lysosomal membrane is a highly dynamic environment where specific interactions among 
proteins and between proteins and lipids occur. These interactions are necessary for the proper 
functioning of the lysosomal apparatus for allowing the passage of molecules into and out of 
the lysosomes. Interestingly, presence of detergent resistant microdomains (DRM) on the 
lysosomal membrane that are enriched in particular proteins has been reported by our group 
(Taute et al., 2002). These domains are of low buoyant density, and very resistant to non-
ionic detergents such as Triton X-100; the characteristics exploited to isolate and study the 
raft complexes. 
 
The DRMs are enriched in cholesterol and sphingolipids. In the lysosomes, the 
mobilisation of cholesterol depends on Niemann-Pick proteins C-1 and C-2 that are 
components of the membrane and matrix respectively. Defects in these proteins cause 
lysosomal storage disorders characterised by an accumulation of lipids, especially 
sphingomyelin and cholesterol in the degradative compartments. These mutations cause the 
C1 and C2 type Niemann-Pick syndromes. It was postulated that one sequela of these 
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lipidoses might be an accumulation of DRMs in endosomes and lysosomes (Simons and 
Ehehalt, 2000).  
 
The detergent resistant microdomains were isolated from the purified lysosomal 
membranes as shown in the following chart. The fractions containing the DRMs were 
enriched in characteristic proteins that made a proteomic profiling of these domains 
interesting to look at. Among the proteins enriched in the low-density fractions, several 
membrane proteins of the lysosomal origin were observed by activity measurements including 
the lysosomal membrane acetyl transferase and the V-type ATPase. 
 
SDS-PAGE Mass spectrometry
(Maldi-TOF) 
(Extraction with Triton X-100 at 4 ° C)
(Floatation on Optiprep TM density gradient) 
Detergent resistant microdomains 
Purified lysosomal membrane
V-ATPase, 
AcTf 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2: Analysis of DRM-associated proteins from the lysosomal membrane  
 
Though the low-density DRM fractions showed enrichment in the activity of AcTf, 
the total yield was as low as 10-12 %. The detergent, Triton X-100 used for the DRM 
analyses was found to diminish the activity of this enzyme. Concerning the low yield, it is not 
known if the detergent inhibits the enzyme or causes the separation of an yet unknown 
subunit of the enzyme. Use of other detergents including CHAPS, NP-40 or Lubrol was not 
suitable for the DRM isolation since no floatation of the protein was obtained under these 
conditions. 
 
Identification of the human lysosomal membrane V-ATPase as a component of DRMs 
is novel though there are earlier reports regarding the localisation of several plasma 
membrane ATPases (Sepulveda et al., 2005, Pang et al., 2005) as well as the yeast vacuolar 
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ATPase (Opekarova et al., 2005) in these domains.  It has been experimentally proven that 
cholesterol depletion by methyl-ß-cyclodextrin, on V-ATPase complex isolated from synaptic 
vesicles of rat brain resulted in the decrease of the enzyme activity (Yoshinaka et al., 2004). 
In the current experiments for isolating the DRMs by floatation experiments, a correlating 
result was obtained, as there was no floatation of V-ATPase or any other proteins after the 
MBCD treatment. The cholesterol-rich DRMs might be a critical factor for the proper subunit 
structure and or the activity the V-ATPase. 
 
Though the DRM fractions showed V-ATPase activity only 4 of the subunits were 
identified in these low-density fractions (subunits V1B, V1D, V1E and V0a). The extreme 
hydrophobicity of the subunits that are part of the V0 domain might be a limiting factor for a 
good solubilisation and resolution of these subunits in the gel system used for the current 
experiments. When the mass spectrometric analysis was carried out to identify the proteins 
present in the lysosomal DRMs, the subunit of V-ATPase mentioned V0a was identified at the 
junction between the stacking gel and separation gel with a significant mowse score of 83. In 
the Western blotting experiments it was observed that upon detergent solubilisation of the 
membrane proteins the V0a tend to precipitate thereby preventing its entry into the gels during 
protein separation (see Fig. 4.7).  This could occur with the other subunits of the complex as 
well.  
 
The association of V-ATPase with the detergent resistant microdomains of the 
lysosomal membrane made the isolation and reconstitution the protein complex interesting to 
look at. This attempt provided a system to study the effect of lipids on the biological activity 
of the complex upon reconstitution and the effect of chemical derivatives that are likely to 
influence the biological activity. 
 
5.3  Isolation of V-ATPase 
A major problem faced during the purification procedure was that the dense pool contained 
both V-ATPase and mitochondrial ATPase (F-type) activities. This was solved to a very high 
extent by removing the mitochondrial contamination by disruption of the dense pool with 
MME and the subsequent incubation with MgCl2. In evaluating the purification procedure, an 
advantage was taken from the differential sensitivities of the ATPases towards NEM. Several 
strategies were examined for the isolation of V-ATPase from the detergent solubilised 
lysosomal membranes. The protein complex has 13 major subunits and 2 accessory 
polypeptides (Smith et al., 2003), and any treatment resulting in either the removal of one or 
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several subunits or depletion of lipid moieties resulted in considerable loss of activity making 
the enzyme difficult to isolate.  
 
Several biochemical techniques including ion-exchange chromatographic procedures,  
blue-native electrophoresis, glycerol density gradient and affinity chromatography (using 
immobilised ATP) were implemented for isolating the complex, but with limited success. 
Separation of detergent solubilised lysosomal membranes by gel filtration resulted in a good 
degree of purification of the NEM-sensitive ATPase activity from majority of the proteins as 
well as from the contaminating ATPases. During the course of purification, the separation and 
enrichment of V-ATPase was confirmed by checking the reactivity to inhibitors of V-type 
ATPases, either N-ethyl maleimide (Hunt and Sanders, 1996) or bafilomycin A-1 
(Schuhmann and Grond, 2004). 
 
In the initial gel filtration experiments, there were several polypeptides present in the 
vacuolar ATPase activity fractions (fractions 9-13). It was found that several of them could be 
removed if the membranes were treated with 20 mM methyl-ß-cyclodextrin prior to the 
extraction. This could well be explained on the basis of depletion of cholesterol by MBCD. 
Due to the treatment, the activity of V-ATPase was partially quenched. However, the decrease 
in the activity was out-weighed by the subsequent increase in the purity. For example, the 
activity for the lysosomal AcTf, which in the preliminary experiments was co-localised with 
V-ATPase was shifted to a lower molecular weight area (fractions 13-17) upon the treatment 
with MBCD. The membranes are likely to contain different kinds of DRMs that may be 
enriched in different sets of proteins of different properties. Interestingly, the fractions 
showing AcTf activity obtained by gel filtration were devoid of all the predominant proteins, 
though the yield of this enzyme was only around 15 %. It should be feasible to optimise the 
system to improve the recovery by altering the temperature and the detergent compositions 
and enhance the chances to isolate and characterise this interesting protein. 
 
After the purification of V-ATPase by gel filtration, the samples were analysed in 
acrylamide gels. The accessory subunit of the enzyme -designated as Ac-45-was a major spot 
found in the two-dimensional electrophoretic pattern as compared to previous mass 
spectrometric results. However, several of the subunits (C, D, E, G, c, c`, c``) that are part of 
the complex possess a basic isoelectric point, and this might explain why these were not 
detected in the two-dimensional systems used. As an alternative, a diagonal separation was 
introduced with a cationic detergent CETAB for the solubilisation and separation of proteins 
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in the first dimension followed by SDS-PAGE in the second dimensional separation. In this 
system, unlike in the regular two-dimensional systems, it was also possible to recover 
extremely hydrophobic polypeptides (Bernd Schroeder, personal communication). 
 
The purification of V-ATPase was confirmed by separating the activity fractions in a 
preparative diagonal electrophoresis and mass spectrometric identification of the obtained 
polypeptides. Though the fractions showed NEM-sensitive ATPase activity, only 6 subunits 
of the protein complex were identified from the gel with significant MOWSE score. They 
were V1A, V1B, V1C, V1D and V1E in addition to one subunit from the V0 domain- V0d. 
These results correlated to the subunit stoichiometry of the complex, as the subunits that are 
present in the high copy numbers and low hydrophobicity are identified through mass 
spectrometry. It is likely that several unidentified spots contain hydrophobic polypeptides of 
the V-ATPase complex that do not provide sufficient number of peptides by tryptic digestion 
making the identification by the Maldi-TOF method inefficient.   
 
Apart from the identified V-ATPase subunits, these fractions of gel filtration also 
contained placental alkaline phosphatase and stomatin. Presence of both these proteins- 
known members of the DRM-associated protein family (Snyers et al., 1999, Mairhofer et al., 
2002) in the V-ATPase activity fractions suggested that MBCD treatment resulted in only a 
partial depletion of DRMs. The cyclodextrin treatment is likely to disrupt the cholesterol-rich 
DRMs only. 
 
An ideal strategy for the complete exploration on the vacuolar ATPase complex and 
its interaction partners might be a combination of blue-native electrophoresis with LC-
nanospray-MS/MS analysis as reported for the hydrophobic membrane complexes from 
mitochondria (Fandino et al., 2005). Unfortunately, such a technique was not available to us. 
The glycolytic enzyme aldolase  (Lu et al., 2001, Lu et al., 2004) and the cytoskeletal protein 
actin (Vitavska et al., 2005) were reported to interact with V-ATPase. A complex molecule- 
RAVE has been reported to be required for the assembly of the V-ATPase complex in yeast 
(Samrdon et al., 2002) but no such molecule has been characterised from the human system 
so far. An attempt to find human homologues of this protein by BLAST performance could 
not yield any match. On this perspective, a complete proteomic analysis of the V-ATPase 
activity fractions obtained through gel filtration would enlighten the subunit composition of 
the lysosomal ATPase and the kind of polypeptides it interacts with.  
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5.4  Reconstitution of V-ATPase 
The vacoular proton pump residing in the lysosomal membrane has an important role in 
maintaining the acidic mileu in the lysosomal lumen, which is required by the lysosomal 
hydrolases.  If the proton translocation or ATP hydrolysis by the V-ATPase is impaired, the 
lysosomal homeostasis is altered with lethal effects. A major pathological sequela is the age-
related macular degeneration (ARMD). Lipids and several products of lipid peroxidation have 
been found to play a critical role in the development of this disease (Kopitz et al., 2004). The 
pathogenesis of ARMD is characterised by deposition of auto-fluorescent bodies of lipofuscin 
in the retinal pigment epithelial (RPE) lysosomes. A major lipofuscin derivative designated as 
A2-E has been suggested to take part in the development of ARMD through an inhibition on 
the V-ATPase (Bergmann et al., 2004). The purification of V-ATPase provided an 
opportunity for reconstituting the protein into liposomes in order to study the in vitro 
inhibitory effects of A2-E among a few other inhibitors, in a defined lipid environment. 
 
The V-ATPase fractions from gel filtration were reconstituted into uni-lamellar 
liposomes made of egg yolk lecithin. A lipid:lipid ratio of 1:1 (w/w) and lipid:protein ratio of 
1:3 (w/w) has been reported to be ideal for the reconstitution of Na, K-ATPase (de Lima 
Santos et al., 2005) using phosphatdyl choline and phosphatidyl ethanolamine. It is also 
known that presence of cholesterol (40 mole %) during the reconstitution decreased the 
optimal chain length of the phospholipids from 22 to 18 (Cornelius, 2001) referring to the 
importance of the hydrophobic matching of the bilayer. However, an attempt to reconstitute 
the lysosomal membrane proteins showed good results when a concentration of 22.5 % 
(mg/mg) cholesterol was used, which was adopted for the V-ATPase reconstitution from 
thereon. Presence of cholesterol during the reconstitution improved the recovery of V-ATPase 
as measured by the inorganic phosphate determination. In the absence of cholesterol, only 
14.5 % of the initial activity was incorporated into the vesicles, whereas 30-32 % of the total 
activity was recovered in the experiments using 22.5 % (mg/mg) cholesterol.  
 
The proteins incorporated into the liposomes were analysed in a two-dimensional 
(diagonal) electrophoresis. After silver staining, in the reconstituted fraction a protein profile 
was observed that was comparable to that of the starting material. The protein spots ranged in 
apparent molecular weights between 30 and 100 kDa. A group of polypeptides (50-100 kDa) 
that were aggregated due to a possible denaturation during the reconstitution of the vesicles 
corresponded to the major signals in the starting material. A small portion of the protein 
 80
CHAPTER 5. DISCUSSION                              
remained in the final soluble fraction and contained mainly polypeptides of relatively low 
apparent molecular weight (20-30 kDa). 
 
5.5   Inhibition studies on the reconstituted V-ATPase 
The reconstituted V-ATPase was used for analysing the effect of various inhibitors on the 
ATPase activity. In the initial phase of this study, the ATPase activity from dense pool 
preparations was checked for its sensitivity towards sodium azide, and was found to show a 
partial inhibitory effect. Sodium azide inhibits generally the F-type ATPases, but has been 
reported to inhibit the proton translocation by V-ATPases at 0.2-0.4 mM concentrations 
(Vasilyeva and Forgac, 1998). However, the toxic compound showed no effect on the ATP 
hydrolysis in the experiments using the purified and reconstituted ATPase.  
 
Several inhibitors were introduced in the assay system to understand their influence of 
ATPase activity after reconstitution. The chemical N-ethylmaleimide, which modifies the -SH 
groups adjacent to the ATP binding pocket, is a well-studied inhibitor of V-type ATPases 
(Hunt and Sanders, 1996). NEM can also affect the P-type ATPase activity whereas the  
F-type ATPases are resistant to it. In the current study, the reconstituted V-ATPase was 
observed to be sensitive to NEM. At a concentration of 2 mM, the ATPase activity was 
inhibited 95 % as reported in the case of V-ATPase from the rat liver lysosomes (Arai et al., 
1992). Thus, the inhibition of the reconstituted enzyme is similar to that of the native form. 
 
Bafilomycin A-1 is a macrolide antibiotic with a high specificity to V-type ATPases 
(Gagliardi et al., 1999). It has been known that the macrolactone ring of the molecule 
contributes to the inhibitory effects (Drose and Altendorf, 1996) and is likely to exert the 
effect through a non-competitive mechanism. As most other V-ATPases, the reconstituted 
ATPase from the lysosomal membrane was sensitive to bafilomycin A-1. The inhibition was 
almost complete when a bafilomycin concentration of 100 nM was used, as was the case with 
the rat liver enzyme. 
 
N-Retinylidene-N-retinylethanolamine (A2-E, see Fig. 1.3), a major lipofuscin 
derivative is one among the compounds deposited in the retinal pigment epithelial cells in 
cases of age-related macular degeneration (ARMD) resulting in irreversible vision loss. It has 
been reported that the fluorogenic material, A2-E, an inhibitor of the lysosomal proton pump 
(Bergmann et al., 2004) might be one factor linked to the pathological condition. A2-E is also 
shown to affect the membrane integrity due to a detergent-like effect and is shown to affect 
the intactness of lysosomal and mitochondrial membranes (Schutt et al., 2002). 
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The effect of A2-E was analysed on the reconstituted vacuolar ATPase in the current 
study. The synthetic A2-E was a kind gift from Dr. Kopitz, University of Heidelberg. This 
vitamin A derivative is known to have detergent-like properties, which could be one factor 
behind its inhibitory effects. A2-E dissolved in DMSO was used for the analyses. 
Unfortunately, DMSO interfered with the inorganic phosphate estimation method. However, 
using proper controls the inhibitory effects of A2-E could be unequivocally demonstrated.  
 
Upon incubation with A2-E, the ATPase activity of the proteoliposomes was reduced 
significantly in a dose-dependent manner. The ATPase activity was inhibited to 80 % when 
an A2-E concentration of 10 µM was introduced during the pre-incubation. When the 
extracted lysosomal membranes without separation of the NEM-sensitive ATPase by gel 
filtration were incorporated into the liposomes, the inhibition by A2-E was only partial. At a 
concentration of 10 µM, the inhibition was around 40 % in contrast to the 80 % inhibition 
from the purified protein. Apparently, A2-E is less or nr not inhibitory towards the F-type 
ATPase. The result demonstrates the separation of the A2-E-insensitive and sensitive ATPase 
by the step of solubilisation and gel filtration. 
 
The results shown here is the first report on the isolation of vacuolar ATPase from 
human tissues and its reconstitution into liposomes. The inhibitory studies using A2-E on the 
reconstituted ATPase strengthens a possible role of the lipofuscin-derived products on the 
pathology of age-related macular degeneration, as was proposed by others from studies using 
the cultured cells (Eldred, 1995, Kopitz et al., 2004).  
 
  The ARMD is one among the major causes of vision loss in elderly worldwide. 
Though there are environmental (Seddon et al., 2005) and genetic factors (Tuo et al., 2004, 
Guymer et al., 2005) known to contribute to the development of this disease, further 
investigations on the effect of lipofuscin flurophores on the acidification of lysosomes can 
give a new insight into the lysosomal impairments by these compounds. Such information 
may contribute to a better understanding of the age-related retinal disorders and their 
management or prevention. 
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7  Summary 
 
The lysosomal membrane is a dynamic environment where specific interactions among 
proteins and between proteins and lipids occur. These interactions are necessary for the proper 
functioning of the lysosomal apparatus that allows the passage of molecules into and out of 
the lysosomes for the degradation and recycling. From the previous studies on human 
placental lysosomes, occurrence of detergent resistant microdomains, in which special 
proteins including the acetyl-CoA: α-glucosaminide N-acetyl transferase are localised has 
been reported by Taute et al. (2002).  
 
In an attempt to characterise the proteins that are part of such microdomains from the 
lysosomal membranes, the V-ATPase was found to be enriched in fractions containing the 
DRMs. This protein complex catalyses an ATP dependent proton translocation and is 
responsible for the acidification of the lysosomal lumen. It is known that lipids and lipid 
peroxidation products influence the biological activity of the V-ATPase that may contribute to 
age-related macular degeneration, a major cause of vision loss as reported by Kopitz et al. 
(2004). In this work a method was established for the isolation and reconstitution of the 
human V-ATPase which should allow further studies on the role of special lipids and lipid 
derivatives on the macular degeneration. 
 
To isolate the V-ATPase, a simple and efficient system for purifying the lysosomal 
membrane proteins was sought as the commonly used procedures yield lysosomal 
preparations that are contaminated with mitochondria. To reduce the contamination, a 
substrate-induced selective disruption of the lysosomal vesicles followed by aggregating and 
sedimenting the bulk of contaminating membranes, especially those from the mitochondria, 
was developed. A purification of the lysosomal membrane proteins up to 300 fold as 
compared to the placental homogenate, based on the specific activity of the membrane-
associated ß-glucosidase was achieved using this novel and convenient procedure. The 
lysosomal membranes thus prepared may also be used for the selective isolation and 
characterisation of lysosomal membrane proteins that are not yet studied in detail, like the 
acetyl-CoA: α-glucosaminide N-acetyl transferase and Niemann- Pick C1 protein known to be 
involved in the degradation of heparan sulphate and in cholesterol transport, respectively. 
 
From the purified lysosomal membranes, the V-ATPase was extracted using Triton X-
100 and CHAPS and further purified by gel filtration. This is the first report on the 
purification of V-ATPase from a human tissue. Methyl-ß-cyclodextrin was included during 
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the extraction step to deplete cholesterol and thereby to disrupt the microdomains. Since a 
number of the V-ATPase subunits possess a basic isoelectric point, and as such are difficult to 
be analysed by the common two-dimensional electrophoretic systems, a novel CETAB/SDS-
PAGE system was used for the proteomic characterisation of the purified V-ATPase. The V-
ATPase activity fractions were devoid of all the major proteins present in the lysosomal 
preparation used for gel filtration, though two other DRM-associated proteins, placental 
alkaline phosphatase and stomatin were identified pointing towards the possibility of different 
types of DRMs on the lysosomal or the contaminating membranes, that were not removed 
during the purification steps. 
 
The purified protein complex was successfully reconstituted into unilamellar vesicles. 
When the vesicles containing lecithin and cholesterol were used for the reconstitution, a 
recovery of upto 30 % was observed in the incorporated fraction, as compared to 14 % when 
the experiment was performed with cholesterol-free vesicles. Finally, the dose-dependant 
inhibitory effects of the lipofuscin componenent, A2-E were confirmed with the reconstituted 
V-ATPase. The ATP hydrolysis by the enzyme was completely inhibited at an A2-E 
concentration of 10 µM. This result extends the previous findings using cell cultures on the 
inhibition of V-ATPase by A2-E described by Bergmann et al. suggesting a role of A2-E in 
the pathogenesis of age-related macular degeneration.  The inhibition of ATP hydrolysis and 
thereby of the lysosomal acidification may cause an accumulation of lipofuscin within the 
lumen of the lysosomes and thus contribute to the degeneration of the retinal epithelium. The 
purified and reconstituted enzyme may facilitate further studies on its inhibitory and 
protective agents. 
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7  Zusammenfassung 
 
Eine Reinigung von lysosomalen Membranen aus humaner Plazenta, bei der sich die 
spezifische Aktivität der membranassoziierten ß-Glucocerebrosidase gegenüber dem 
Homogenat 300-fach anreichern ließ, wurde erzielt. Aus diesen Membranpräparationen 
konnte die vakuoläre H+-ATPase extrahiert und durch Gelfiltration weiter gereinigt werden. 
Dies ist die erste Beschreibung einer Solubilisierung und Anreicherung der V-ATPase aus 
humanem Gewebe. Weiterhin konnte gezeigt werden dass sich der Enzymkomplex aus 
detergenzresistenten Mikrodomänen (DRMs, rafts) durch Methyl-ß-cyclodextrin freisetzen 
ließ. Neben einigen V-ATPase Untereinheiten ließen sich die alkalische Phosphatase und 
Stomatin als weitere DRM-assoziierte Proteine durch Kombination von CETAB- und SDS-
PAGE mit anschießendem MALDI-Massen-Fingerprint identifizieren, die unter Methyl-ß-
cyclodextrin-Behandlung jedoch nicht freigesetzt wurden. Des Weiteren konnten in 
Rekonstitutionsversuchen 30 % der gereinigten V-ATPase-Aktivität in Cholesterol-haltigen 
und 14 % in Cholesterol-freien Liposomen erhalten werden. Die Aktivität der V-ATPase in 
den gereinigten lysosomalen Membranen und ebenso diejenige des in Liposomen 
rekonstituierten Enzyms erwies sich als vollständig mit dem Retinalderivat A2-E (10 µM) 
hemmbar. Dadurch wurde eine Basis für weitere Untersuchungen des pathogenetischen 
Potentials des A2-E geschaffen. 
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8  Appendix 
 
8.1    Abbreviations and expressions 
 
ABC    ATP Binding cassette 
Ac-45    Accessory protein-45 
AcTf        Acetyl transferase 
A2-E     N-Retinylidene-N-retinylethanolamine  
APS     Ammonium peroxisulphate 
AP    Adaptor protein 
ASB-14    Amidosulfobetaine-14 
Arf    ADP-ribosylation factor 
ARMD     Age-related macular degeneration 
ATP    Adenosine triphosphate 
BLAST   Basic local alignment search tool 
BSA    Bovine serum albumin 
CHAPS    3-[(3-cholamidopropyl)-dimethylammonio]- propanesulfonate 
cDNA    complementary DNA 
CLN-proteins     Neuronal ceroid lipofuscinos-associated proteins 
cm     Centimeter 
CoA      Coenzyme A 
Da    Dalton 
°C     Degree celcius 
DP    Dense pool 
DNA     Deoxy ribonucleic acid 
DMSO     Dimethyl sulphoxide 
DTT     Dithiothreitol 
ECL    Enhanced chemi luminiscence 
EC     Enzyme commission 
ER     Endoplasmic reticulum 
EDTA     Ethylinediamine tetraacetate 
et al.     and others (Latin) 
GRAVY score    Grand average hydrophobicity score 
GGA    Golgi-localized γ-ear-containing, Arf binding proteins 
g     Gram 
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ß-Gluc    ß-Glucocerebrosidase 
HPLC    High performance lipid chromatography 
HRP    Horse radish peroxidase 
h     Hour 
IgG    Immunoglobulin 
IEF     Isoelectric focusing 
kDa    kilo Dalton 
LAMP    Lysosome associated membrane protein 
MS    Mass spectrometry 
LIMP    Lysosomal integral membrane protein 
Maldi-TOF     Matrix-assisted laser desorption/ionisation- Time-of-flight 
µl    Microliter 
min      Minute 
mA     Milli ampere 
ml     Milliliter 
mm     Millimeter 
MME     Methionine methyl ester 
MBCD    methyl-ß-cyclodextrin 
MW    Molecular weight 
M    Molar 
nm      nano mole 
NCBI     National Center for Biological Information 
NEM     N-ethylmaleimide 
NADH    Nicotinamide adenine dinucleotide (reduced) 
NPC1    Niemann-Pick-C1 
NPC2    Niemann-Pick-C2 
NP-40    Nonidiet P-40 
ORF    Open reading frame 
Pi     Inorganic phosphate 
pI     Isolectric point 
pH     -log (H+) 
PAGE    Polyacrylamide gel electrophoresis 
PC     Phosphatidyl choline 
PMSF    Phenyl methyl sulphonyl fluoride  
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PLAP    Placental alkaline phosphatase 
PVDF     Polyvinylidene fluoride 
rpm     revolutions per minute 
SDS    Sodium dodecyl sulphate 
SDH    Succinate dehydrogenase 
TEMED    N' N' N' N'-Tetramethylene diamine 
TGN    Trans-golgi-network 
TCA     Trichloroacetic acid 
TPP-1    Tripeptidyl peptidase-1 
2DE     Two-dimensional electrophoresis 
UC        Ultra centrifuge 
UV     Ultra violet 
V-ATPase     Vacuolar ATPase 
v/v    volume/volume 
w/v      weight/volume 
ZFF     Z-Phe-Phe-diazomethyl ketone 
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